Barclays PLC
Q1 2018 Results Announcement
31 March 2018
Performance Highlights
Double digit returns across Barclays UK and Barclays International, and resolution of
a significant legacy litigation matter
• |
Returns: |
• |
Attributable profit was £1.2bn, excluding litigation and conduct charges of £2.0bn principally relating to a £1.4bn settlement with the United States Department of Justice (DoJ) relating to Residential Mortgage-Backed Securities (RMBS) and additional charges of £400m relating to Payment Protection Insurance (PPI) |
• |
Group Return on Tangible Equity (RoTE) was 11.0% (Q117: 2.0%), excluding litigation and conduct, with double digit returns in both Barclays UK and Barclays International |
||
• |
Group RoTE targets of greater than 9% in 2019 and greater than 10% in 2020, excluding litigation and conduct and based on a Group Common Equity Tier 1 (CET1) ratio of c.13% |
||
• |
Cost efficiency: |
• |
Group operating expenses decreased 6% to £3.4bn, resulting in a cost: income ratio of 63% (Q117: 62%), excluding litigation and conduct of £2.0bn (Q117: £28m) |
• |
Guidance for Group operating expenses of £13.6-13.9bn in 2019, excluding litigation and conduct |
||
• |
Capital and dividends: |
• |
CET1 ratio declined to 12.7% (December 2017: 13.3%), as organic capital generation from profits was more than offset by a 61bps impact from litigation and conduct charges, and a £4.9bn increase in risk weighted assets (RWAs) |
• |
Final dividend of 2.0p per share for 2017 was paid on 5 April 2018 |
||
• |
Reiterated intention to pay a dividend of 6.5p per share for 2018, subject to regulatory approvals |
• |
Group loss before tax was £236m (Q117: profit of £1,682m). Excluding litigation and conduct, profit before tax increased 1% to £1,725m driven by a 45% improvement in credit impairment charges, primarily reflecting single name recoveries in wholesale and the improved macroeconomic forecasts in the US, and a 6% reduction in operating expenses, partially offset by an 8% decline in income. Results were impacted by the 12% depreciation of average USD against GBP |
|
|
- |
Barclays UK RoTE was negative 1.1% (Q117: positive 21.6%). Excluding litigation and conduct, RoTE was 15.7% (Q117: 21.5%) as profit before tax decreased to £581m (Q117: £704m) reflecting 3% lower income, a 5% increase in operating expenses due to increased investment and a 13% increase in credit impairment charges |
|
- |
Barclays International RoTE was 13.4% (Q117: 12.5%), with double digit returns in both the Corporate and Investment Bank (CIB) and Consumer, Cards and Payments. Profit before tax increased 4% to £1,413m driven by a 73% decrease in credit impairment charges and a 5% reduction in operating expenses, while income declined 8% |
• |
Attributable loss was £764m (Q117: profit of £190m), including litigation and conduct charges, and basic loss per share was 4.2p (Q117: earnings per share of 1.3p). Excluding litigation and conduct, earnings per share was 7.1p (Q117: 1.5p) |
|
• |
Tangible net asset value per share decreased to 251p (December 2017: 276p) primarily due to the impact of the implementation of IFRS 9, litigation and conduct charges in the quarter, and adverse movements across the currency translation and cash flow hedging reserves |
James E Staley, Group Chief Executive Officer, said:
"This has been a significant quarter for Barclays, one in which we have shown that our new operating model and our portfolio of diversified, profitable businesses are capable of producing improved returns for shareholders.
Our transatlantic wholesale and consumer bank has produced a Group Return on Tangible Equity (RoTE) of 11.0%, excluding litigation and conduct, with both Barclays UK and Barclays International delivering double digit returns.
Demonstrating the benefits of diversification, lower revenues in our UK businesses, driven by one-offs, were offset by a stronger performance in Barclays International, particularly in the Corporate and Investment Bank, which reported profit before tax up 49% and a RoTE of 13.0%.
The first quarter is typically a strong one of course, but this performance does increase confidence in our capacity to meet our Group RoTE targets of greater than 9% in 2019, and greater than 10% in 2020, excluding litigation and conduct and based on a Group CET1 ratio of c.13%.
This quarter we also reached an agreement with the US Department of Justice to resolve issues related to the sale of Residential Mortgage-Backed Securities between 2005 and 2007. While the penalty was substantial, this settlement represents a major milestone for Barclays, putting behind us a significant decade-old legacy matter.
The settlement with the US Department of Justice, together with additional charges relating to PPI, reduced our CET1 ratio by around 60bps to 12.7%, but given the earnings power of the Group, and our strong record in capital management, we are confident that we will get back to around 13% in good time.
It remains our intention to pay a dividend for 2018 of 6.5p, and we look forward to returning an increasing amount of capital to shareholders, both through the annual dividend, and via other means of return, such as buybacks, going forward."
James E Staley
Group Chief Executive Officer
Barclays Group results |
|
|
|
for the three months ended |
31.03.18 |
31.03.17 |
|
|
£m |
£m |
% Change |
Total income |
5,358 |
5,823 |
(8) |
Credit impairment charges and other provisions |
(288) |
(527) |
45 |
Net operating income |
5,070 |
5,296 |
(4) |
Operating expenses excluding litigation and conduct |
(3,364) |
(3,591) |
6 |
Litigation and conduct1 |
(1,961) |
(28) |
|
Operating expenses |
(5,325) |
(3,619) |
(47) |
Other net income |
19 |
5 |
|
(Loss)/profit before tax |
(236) |
1,682 |
|
Tax charge |
(304) |
(473) |
36 |
(Loss)/profit after tax in respect of continuing operations |
(540) |
1,209 |
|
Loss after tax in respect of discontinued operation |
- |
(658) |
|
Non-controlling interests in respect of continuing operations |
(53) |
(79) |
33 |
Non-controlling interests in respect of discontinued operation |
- |
(143) |
|
Other equity instrument holders2 |
(171) |
(139) |
(23) |
Attributable (loss)/profit |
(764) |
190 |
|
|
|
|
|
Performance measures |
|
|
|
Return on average tangible shareholders' equity2 |
(6.5%) |
1.8% |
|
Average tangible shareholders' equity (£bn) |
44.2 |
49.4 |
|
Cost: income ratio |
99% |
62% |
|
Loan loss rate (bps) |
36 |
47 |
|
Basic (loss)/earnings per share2 |
(4.2p) |
1.3p |
|
Basic (loss)/earnings per share in respect of continuing operations2 |
(4.2p) |
6.1p |
|
|
|
|
|
Performance measures excluding litigation and conduct1 |
|
|
|
Profit before tax |
1,725 |
1,710 |
1 |
Attributable profit |
1,166 |
209 |
|
Return on average tangible shareholders' equity2 |
11.0% |
2.0% |
|
Cost: income ratio |
63% |
62% |
|
Basic earnings per share2 |
7.1p |
1.5p |
|
|
|
|
|
|
As at |
As at |
As at |
Balance sheet and capital management3 |
31.03.18 |
31.12.17 |
31.03.17 |
Tangible net asset value per share |
251p |
276p |
292p |
Common equity tier 1 ratio |
12.7% |
13.3% |
12.5% |
Common equity tier 1 capital (£bn) |
40.2 |
41.6 |
44.9 |
Risk weighted assets (£bn) |
317.9 |
313.0 |
360.9 |
Average UK leverage ratio4 |
4.6% |
4.9% |
4.6% |
Average tier 1 capital4 (£bn) |
50.0 |
51.2 |
52.3 |
Average UK leverage exposure4 (£bn) |
1,090 |
1,045 |
1,130 |
|
|
|
|
Funding and liquidity |
|
|
|
Group liquidity pool (£bn) |
207 |
220 |
185 |
CRD IV liquidity coverage ratio |
147% |
154% |
140% |
Loan: deposit ratio5 |
84% |
81% |
85% |
1 |
Refer to pages 29-33 for further information and calculations of performance measures excluding litigation and conduct. |
2 |
The profit after tax attributable to other equity instrument holders of £171m (Q117: £139m) is offset by a tax credit recorded in reserves of £46m (Q117: £38m). The net amount of £125m (Q117: £101m), along with non-controlling interests, is deducted from profit after tax in order to calculate earnings per share and return on average tangible shareholders' equity. |
3 |
Capital, RWAs and leverage measures are calculated applying the IFRS 9 transitional arrangements under Article 473a of the CRR. For more information refer to the Barclays PLC Pillar 3 Report Q1 2018, located at home.barclays/results. |
4 |
The average UK leverage ratio uses capital based on the last day of each month in the quarter and an exposure measure based on each day in the quarter. The comparatives for the average UK leverage exposure were calculated based on the last day of each month in the quarter. Both exclude qualifying central bank claims from the leverage exposure. The UK leverage ratio was 4.8% (December 2017: 5.1%). |
5 |
Loan: deposit ratio is calculated as loans and advances at amortised cost divided by deposits at amortised cost. Comparatives have been restated based on this approach. |
Group Finance Director's Review
In the first quarter of 2018, both Barclays UK and Barclays International delivered double digit returns, driving a Group RoTE of 11.0% excluding litigation and conduct. While Group statutory profits and capital were impacted by the settlement with the US DoJ regarding RMBS and additional charges relating to PPI, this marked an important step towards resolving significant outstanding legacy litigation and conduct matters. Additionally, on 1 April 2018 Barclays successfully established its ring-fenced bank, Barclays Bank UK PLC (BBUKPLC), nine months ahead of the regulatory deadline. Together with the extensive restructuring completed last year, Barclays is now well-positioned to deliver strong earnings going forward and remains confident of achieving its returns and cost targets. Barclays reiterated the intention to pay a 6.5p dividend for 2018, subject to regulatory approvals.
Group performance
• |
RoTE was 11.0% (Q117: 2.0%) and earnings per share was 7.1p (Q117: 1.5p), excluding litigation and conduct |
• |
Loss before tax of £236m (Q117: profit of £1,682m) included litigation and conduct charges of £1,961m (Q117: £28m), principally reflecting the £1.4bn settlement relating to RMBS and additional charges of £400m relating to PPI. Excluding these items, profit before tax increased 1% to £1,725m driven by a 45% decrease in credit impairment charges and a 6% reduction in operating expenses, partially offset by an 8% reduction in income. The 12% depreciation of average USD against GBP adversely impacted profits and income, and positively affected credit impairment charges and operating expenses |
• |
Total income decreased to £5,358m (Q117: £5,823m) driven by a £330m decrease in Barclays International, primarily due to the non-recurrence of a £192m gain relating to an asset sale in US Cards and a £74m valuation gain on Barclays' preference shares in Visa Inc. in Q117, and a £156m decrease in Head Office |
• |
Credit impairment charges decreased 45% to £288m primarily reflecting single name recoveries in wholesale and the improved macroeconomic forecasts in the US. Impairment declined 73% in Barclays International and increased 13% in Barclays UK. The Group loan loss rate decreased 11bps to 36bps |
• |
Operating expenses of £5,325m (Q117: £3,619m) included litigation and conduct charges of £1,961m (Q117: £28m), excluding which, Group operating expenses decreased 6% to £3,364m. This was driven by a 6% reduction in Barclays International and the non-recurrence of costs associated with the former Non-Core division. The cost: income ratio, excluding litigation and conduct, was 63% (Q117: 62%) |
Barclays UK
• |
RoTE declined to negative 1.1% (Q117: positive 21.6%) due to additional charges of £400m (Q117: £nil) relating to PPI. Excluding litigation and conduct charges, RoTE was 15.7% (Q117: 21.5%) as profit before tax decreased 17% to £581m |
|
• |
Total income decreased 3% to £1,788m reflecting the non-recurrence of a valuation gain on Barclays' preference shares in Visa Inc. in Q117 and customer remediation provisions |
|
|
- |
Personal Banking income decreased 6% to £889m driven by the non-recurrence of the Visa gain and a customer remediation provision |
|
- |
Barclaycard Consumer UK income increased 6% to £527m |
|
- |
Wealth, Entrepreneurs & Business Banking (WEBB) income decreased 7% to £372m driven by a customer remediation provision |
• |
Net interest margin decreased 42bps to 3.27% reflecting the integration of the Education, Social Housing and Local Authority (ESHLA) portfolio |
|
• |
Credit impairment charges increased 13% to £201m driven by increased impairment in Personal Banking and a single name case in WEBB, however 30 and 90 day arrears rates in UK cards remained flat at 2.0% (Q117: 2.0%) and 0.9% (Q117: 0.9%), respectively |
|
• |
Operating expenses excluding litigation and conduct increased 5% to £1,005m due to continued investment in digitising the bank, resulting in a cost: income ratio of 56% (Q117: 52%) |
|
• |
RWAs increased to £72.5bn (December 2017: £70.9bn) predominantly as a result of IFRS 9 implementation and asset transfers in preparation for structural reform |
Barclays International
• |
Profit before tax increased 4% to £1,413m resulting in a RoTE of 13.4% (Q117: 12.5%), reflecting double digit returns in both CIB and Consumer, Cards and Payments of 13.0% (Q117: 8.2%) and 15.6% (Q117: 36.4%), respectively |
||
• |
The 12% depreciation of average USD against GBP adversely impacted profits and income, and positively affected credit impairment charges and operating expenses |
||
• |
Total income decreased 8% to £3,808m |
||
|
- |
CIB income increased 1% to £2,799m as Markets income increased 8% to £1,459m, partially offset by a decrease in Banking income of 4% to £1,337m |
|
|
|
- |
FICC income decreased 2% to £869m as a strong performance in foreign exchange was offset by a decline in credit |
|
|
- |
Equities income increased 28% to £590m reflecting an improved performance in derivatives as a result of increased client activity and market volatility, and a strong performance in equity financing |
|
|
- |
Banking fee income decreased 6% to £683m from a strong Q117. Global fee share increased across all products compared to Q417 and FY17 |
|
|
- |
Corporate lending declined 11% to £240m driven by the reallocation of RWAs within CIB and lower lending balances due to the realignment of clients between Barclays UK and Barclays International in preparation for structural reform, partially offset by lower losses on fair value hedges |
|
|
- |
Transaction banking increased 4% to £414m driven by higher average deposit balances |
|
- |
Consumer, Cards and Payments income decreased 26% to £1,009m driven by the non-recurrence of a £192m gain relating to an asset sale in US Cards and a £74m valuation gain on Barclays' preference shares in Visa Inc. in Q117. Excluding these items, income declined 7% reflecting the impact of repositioning the US Cards portfolio towards a lower risk mix, partially offset by underlying growth in US Cards |
|
• |
Credit impairment charges decreased 73% to £93m |
||
|
- |
CIB credit impairment charges decreased to a release of £159m (Q117: charge of £51m) primarily due to write-backs and updated macroeconomic forecasts |
|
|
- |
Consumer, Cards and Payments credit impairment charges decreased 15% to £252m due to the impact of repositioning the US Cards portfolio towards a lower risk mix and the improved macroeconomic forecasts in the US, partially offset by increased delinquency rates in US Cards. 30 and 90 day arrears rates within US Cards increased to 2.6% (Q117: 2.3%) and 1.4% (Q117: 1.2%), respectively |
|
• |
Operating expenses decreased 5% to £2,315m |
||
|
- |
CIB operating expenses decreased 8% to £1,786m driven by the reduction of restructuring and structural reform costs, and the reduced impact of the change in compensation awards introduced in Q416 |
|
|
- |
Consumer, Cards and Payments operating expenses increased 4% to £529m reflecting continued growth and investment |
|
• |
RWAs increased to £214.2bn (December 2017: £210.3bn) due to increased trading activity |
Head Office
• |
Loss before tax was £1,819m (Q117: £141m) |
• |
Total income reduced to an expense of £238m (Q117: expense of £82m) reflecting certain legacy capital instrument funding costs now charged to Head Office of £88m in Q118, hedge accounting and an increased net expense from treasury operations |
• |
Operating expenses increased to £1,594m (Q117: £59m) reflecting an increase in litigation and conduct charges, including the settlement relating to RMBS, and costs associated with former Non-Core assets and businesses which were integrated on 1 July 2017. Excluding litigation and conduct charges, operating expenses were £59m (Q117: £49m) |
• |
RWAs decreased to £31.2bn (December 2017: £31.8bn) |
Group capital and leverage
• |
The CET1 ratio decreased to 12.7% (December 2017: 13.3%) due to a decrease in CET1 capital of £1.3bn to £40.2bn and an increase in RWAs of £4.9bn to £317.9bn |
|
|
- |
Organic capital generation from profits of £1.3bn were more than offset by litigation and conduct charges, including £1.4bn from the settlement relating to RMBS and additional charges of £0.4bn relating to PPI |
|
- |
The implementation of IFRS 9 on 1 January 2018 resulted in a net increase in CET1 capital as the £2.2bn decrease in shareholders' equity on initial adoption was more than offset by the application of transitional relief of £1.3bn and the removal of the £1.2bn excess of expected loss over impairment capital deduction |
|
- |
The increase in RWAs was principally due to business growth in investment banking businesses, offset by the depreciation of period end USD against GBP |
· |
The average UK leverage ratio decreased to 4.6% (December 2017: 4.9%) primarily driven by increased exposures due to securities financing transactions and trading portfolio assets trading activity, as well as the decrease in capital |
|
• |
Tangible net asset value per share decreased to 251p (December 2017: 276p) primarily due to the impact of the implementation of IFRS 9, litigation and conduct charges in the quarter, and adverse movements across the currency translation and cash flow hedging reserves |
Group funding and liquidity
• |
The Group continued to maintain surpluses to its internal and regulatory requirements. The liquidity pool decreased to £207bn (December 2017: £220bn) driven largely by the deployment of funding to support business growth. The liquidity coverage ratio decreased to 147% (December 2017: 154%), equivalent to a surplus of £65bn (December 2017: £75bn) to the 100% requirement |
• |
Wholesale funding outstanding excluding repurchase agreements was £147bn (December 2017: £144bn). The Group issued £2.4bn equivalent of term senior unsecured debt from Barclays PLC and £2.1bn from Barclays Bank PLC (BBPLC). In the same period, £0.7bn of Barclays PLC senior unsecured debt and £2.2bn of BBPLC subordinated debt were either called or matured |
Other matters
· |
In Q118 Barclays reached a settlement with the US Department of Justice (DoJ) to resolve the civil complaint brought by the DoJ in December 2016 relating to Residential Mortgage-Backed Securities (RMBS) sold by Barclays between 2005 and 2007. Barclays has agreed to pay a civil monetary penalty of $2,000m (£1,420m), which was recognised in Q118 |
· |
Additional charges of £400m (Q117: £nil) relating to PPI were recognised mainly as a result of continued higher complaints flow in Q118. The remaining PPI provision as at 31 March 2018 was £1.7bn (December 2017: £1.6bn) to cover claims through to the deadline of 29 August 2019. Management views its current PPI provision as appropriate, but will continue to closely monitor complaint trends and the associated provision adequacy |
Structural reform
· |
On 9 March 2018 Barclays was granted approval from the Prudential Regulation Authority (PRA) and the High Court of Justice of England and Wales to implement the "ring-fencing" of Barclays' day-to-day banking services using a legal process called a Ring-Fencing Transfer Scheme (the "Scheme") under Part VII of the Financial Services Markets Act 2000. Barclays implemented the Scheme and established BBUKPLC on 1 April 2018 |
· |
Illustrative, unaudited pro-forma financials as at 31 December 2017 for BBUKPLC and BBPLC have been published and are available at home.barclays/annualreport. More information can be found at home.barclays/about-barclays/ring-fencing-explained |
IFRS 9 Financial Instruments
• |
Barclays adopted IFRS 9 Financial Instruments from 1 January 2018, replacing IAS 39 Financial Instruments: Recognition and Measurement. As a result, shareholders' equity decreased by £2.2bn post-tax, equating to a reduction in tangible net asset value of 13p per share as at 31 March 2018. Barclays elected to apply transitional arrangements, as outlined in Capital Requirements Regulation (CRR) Article 473a. For further detail, please refer to the Barclays PLC IFRS 9 Transition Note that can be found at home.barclays/results |
• |
IFRS 9 requires the recognition of impairment earlier in the lifecycle of a product having considered forward-looking information. As a result, measurement involves more complex judgement with impairment likely to be more volatile as the economic outlook changes. Management continues to closely monitor observed trends |
Tushar Morzaria, Group Finance Director
Quarterly Results Summary
Barclays Group |
|
|
|
|
|
|
|
|
|
|
|
Q118 |
|
Q417 |
Q317 |
Q2171 |
Q1171 |
|
Q4161 |
Q3161 |
Q2161 |
Income statement information |
£m |
|
£m |
£m |
£m |
£m |
|
£m |
£m |
£m |
Net interest income |
2,188 |
|
2,272 |
2,475 |
2,579 |
2,519 |
|
2,523 |
2,796 |
2,530 |
Net fee, commission and other income |
3,170 |
|
2,750 |
2,698 |
2,479 |
3,304 |
|
2,469 |
2,650 |
3,442 |
Total income |
5,358 |
|
5,022 |
5,173 |
5,058 |
5,823 |
|
4,992 |
5,446 |
5,972 |
Credit impairment charges and other provisions |
(288) |
|
(573) |
(709) |
(527) |
(527) |
|
(653) |
(789) |
(488) |
Net operating income |
5,070 |
|
4,449 |
4,464 |
4,531 |
5,296 |
|
4,339 |
4,657 |
5,484 |
Operating expenses excluding UK bank levy and litigation and conduct |
(3,364) |
|
(3,621) |
(3,274) |
(3,398) |
(3,591) |
|
(3,812) |
(3,581) |
(3,425) |
UK bank levy |
- |
|
(365) |
- |
- |
- |
|
(410) |
- |
- |
Litigation and conduct2 |
(1,961) |
|
(383) |
(81) |
(715) |
(28) |
|
(97) |
(741) |
(447) |
Operating expenses |
(5,325) |
|
(4,369) |
(3,355) |
(4,113) |
(3,619) |
|
(4,319) |
(4,322) |
(3,872) |
Other net income/(expenses) |
19 |
|
13 |
(2) |
241 |
5 |
|
310 |
502 |
(342) |
(Loss)/profit before tax |
(236) |
|
93 |
1,107 |
659 |
1,682 |
|
330 |
837 |
1,270 |
Tax (charge)/credit |
(304) |
|
(1,138) |
(324) |
(305) |
(473) |
|
50 |
(328) |
(467) |
(Loss)/profit after tax in respect of continuing operations |
(540) |
|
(1,045) |
783 |
354 |
1,209 |
|
380 |
509 |
803 |
(Loss)/profit after tax in respect of discontinued operation |
- |
|
- |
- |
(1,537) |
(658) |
|
71 |
209 |
145 |
|
|
|
|
|
|
|
|
|
|
|
Attributable to: |
|
|
|
|
|
|
|
|
|
|
Ordinary equity holders of the parent |
(764) |
|
(1,294) |
583 |
(1,401) |
190 |
|
99 |
414 |
677 |
Other equity instrument holders |
171 |
|
181 |
157 |
162 |
139 |
|
139 |
110 |
104 |
Non-controlling interests in respect of continuing operations |
53 |
|
68 |
43 |
59 |
79 |
|
90 |
70 |
92 |
Non-controlling interests in respect of discontinued operation |
- |
|
- |
- |
(3) |
143 |
|
123 |
124 |
75 |
|
|
|
|
|
|
|
|
|
|
|
Balance sheet information |
£bn |
|
£bn |
£bn |
£bn |
£bn |
|
£bn |
£bn |
£bn |
Total assets |
1,142.2 |
|
1,133.2 |
1,149.3 |
1,135.3 |
1,203.8 |
|
1,213.1 |
1,324.0 |
1,351.3 |
Risk weighted assets |
317.9 |
|
313.0 |
324.3 |
327.4 |
360.9 |
|
365.6 |
373.4 |
366.3 |
Average UK leverage exposure |
1,089.9 |
|
1,044.6 |
1,035.1 |
1,092.2 |
1,130.4 |
|
1,137.3 |
n/a |
n/a |
|
|
|
|
|
|
|
|
|
|
|
Performance measures |
|
|
|
|
|
|
|
|
|
|
Return on average tangible shareholders' equity |
(6.5%) |
|
(10.3%) |
5.1% |
(11.0%) |
1.8% |
|
1.1% |
3.6% |
5.8% |
Average tangible shareholders' equity (£bn) |
44.2 |
|
48.1 |
48.9 |
49.3 |
49.4 |
|
48.9 |
49.4 |
48.3 |
Cost: income ratio |
99% |
|
87% |
65% |
81% |
62% |
|
87% |
79% |
65% |
Loan loss rate (bps) |
36 |
|
56 |
66 |
49 |
47 |
|
58 |
66 |
41 |
Basic (loss)/earnings per share |
(4.2p) |
|
(7.3p) |
3.7p |
(8.0p) |
1.3p |
|
0.8p |
2.6p |
4.2p |
Basic (loss)/earnings per share in respect of continuing operations |
(4.2p) |
|
(7.3p) |
3.7p |
1.0p |
6.1p |
|
1.1p |
2.1p |
3.8p |
|
|
|
|
|
|
|
|
|
|
|
Performance measures excluding litigation and conduct2 |
£m |
|
£m |
£m |
£m |
£m |
|
£m |
£m |
£m |
Profit before tax |
1,725 |
|
476 |
1,188 |
1,374 |
1,710 |
|
427 |
1,578 |
1,717 |
Attributable profit/(loss) |
1,166 |
|
(943) |
660 |
(698) |
209 |
|
151 |
1,140 |
1,124 |
Return on average tangible shareholders' equity |
11.0% |
|
(7.4%) |
5.7% |
(5.3%) |
2.0% |
|
1.6% |
9.5% |
9.5% |
Cost: income ratio |
63% |
|
79% |
63% |
67% |
62% |
|
85% |
66% |
57% |
Basic earnings/(loss) per share |
7.1p |
|
(5.3p) |
4.1p |
(3.8p) |
1.5p |
|
1.1p |
6.9p |
6.8p |
1 |
Results include Barclays Non-Core and the Africa Banking discontinued operation; refer to pages 27-28 for further detail. |
2 |
Refer to pages 29-33 for further information and calculations of performance measures excluding litigation and conduct. |
Quarterly Results by Business
Barclays UK |
|
|
|
|
|
|
|
|
|
|
|
Q118 |
|
Q417 |
Q317 |
Q217 |
Q117 |
|
Q416 |
Q316 |
Q216 |
Income statement information |
£m |
|
£m |
£m |
£m |
£m |
|
£m |
£m |
£m |
Net interest income |
1,493 |
|
1,540 |
1,501 |
1,534 |
1,511 |
|
1,502 |
1,569 |
1,476 |
Net fee, commission and other income |
295 |
|
330 |
351 |
286 |
330 |
|
326 |
374 |
467 |
Total income |
1,788 |
|
1,870 |
1,852 |
1,820 |
1,841 |
|
1,828 |
1,943 |
1,943 |
Credit impairment charges and other provisions |
(201) |
|
(184) |
(201) |
(220) |
(178) |
|
(180) |
(350) |
(220) |
Net operating income |
1,587 |
|
1,686 |
1,651 |
1,600 |
1,663 |
|
1,648 |
1,593 |
1,723 |
Operating expenses excluding UK bank levy and litigation and conduct |
(1,005) |
|
(1,117) |
(980) |
(974) |
(959) |
|
(989) |
(904) |
(947) |
UK bank levy |
- |
|
(59) |
- |
- |
- |
|
(48) |
- |
- |
Litigation and conduct1 |
(411) |
|
(53) |
(11) |
(699) |
4 |
|
(28) |
(614) |
(399) |
Operating expenses |
(1,416) |
|
(1,229) |
(991) |
(1,673) |
(955) |
|
(1,065) |
(1,518) |
(1,346) |
Other net (expenses)/income |
(1) |
|
(5) |
1 |
(1) |
- |
|
- |
- |
(1) |
Profit/(loss) before tax |
170 |
|
452 |
661 |
(74) |
708 |
|
583 |
75 |
376 |
Attributable (loss)/profit |
(38) |
|
245 |
423 |
(285) |
470 |
|
383 |
(163) |
141 |
|
|
|
|
|
|
|
|
|
|
|
Balance sheet information |
£bn |
|
£bn |
£bn |
£bn |
£bn |
|
£bn |
£bn |
£bn |
Loans and advances to customers at amortised cost |
184.3 |
|
183.8 |
182.2 |
166.6 |
164.5 |
|
166.4 |
166.6 |
166.0 |
Total assets |
235.2 |
|
237.4 |
230.4 |
203.4 |
203.0 |
|
209.6 |
209.1 |
204.6 |
Customer deposits at amortised cost |
192.0 |
|
193.4 |
189.3 |
187.4 |
184.4 |
|
189.0 |
185.5 |
181.7 |
Loan: deposit ratio2 |
96% |
|
95% |
97% |
89% |
90% |
|
89% |
91% |
92% |
Risk weighted assets |
72.5 |
|
70.9 |
70.0 |
66.1 |
66.3 |
|
67.5 |
67.4 |
67.1 |
Period end allocated tangible equity |
9.8 |
|
9.6 |
9.5 |
8.6 |
8.8 |
|
8.5 |
8.5 |
8.6 |
|
|
|
|
|
|
|
|
|
|
|
Performance measures |
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity |
(1.1%) |
|
10.7% |
18.4% |
(12.7%) |
21.6% |
|
18.2% |
(7.1%) |
6.6% |
Average allocated tangible equity (£bn) |
9.8 |
|
9.6 |
9.4 |
8.7 |
8.9 |
|
8.6 |
8.7 |
9.0 |
Cost: income ratio |
79% |
|
66% |
54% |
92% |
52% |
|
58% |
78% |
69% |
Loan loss rate (bps) |
43 |
|
39 |
43 |
52 |
43 |
|
42 |
82 |
52 |
Net interest margin |
3.27% |
|
3.32% |
3.28% |
3.70% |
3.69% |
|
3.56% |
3.72% |
3.56% |
|
|
|
|
|
|
|
|
|
|
|
Performance measures excluding litigation and conduct1 |
£m |
|
£m |
£m |
£m |
£m |
|
£m |
£m |
£m |
Profit before tax |
581 |
|
505 |
672 |
625 |
704 |
|
611 |
689 |
775 |
Attributable profit |
373 |
|
282 |
431 |
406 |
467 |
|
380 |
464 |
551 |
Return on average allocated tangible equity |
15.7% |
|
12.3% |
18.7% |
19.1% |
21.5% |
|
18.0% |
21.6% |
24.9% |
Cost: income ratio |
56% |
|
63% |
53% |
54% |
52% |
|
57% |
47% |
49% |
1 |
Refer to pages 29-33 for further information and calculations of performance measures excluding litigation and conduct. |
2 |
Loan: deposit ratio is calculated as loans and advances to customers at amortised cost and loans and advances to banks at amortised cost of £0.4bn (Q417: £0.5bn), divided by customer deposits at amortised cost and deposits from banks at amortised cost of £nil (Q417: £nil). Comparatives have been restated to include loans and advances to banks at amortised cost and deposits from banks at amortised cost. |
Analysis of Barclays UK |
|
|
|
|
|
|
|
|
|
|
|
Q118 |
|
Q417 |
Q317 |
Q217 |
Q117 |
|
Q416 |
Q316 |
Q216 |
Analysis of total income |
£m |
|
£m |
£m |
£m |
£m |
|
£m |
£m |
£m |
Personal Banking |
889 |
|
1,020 |
926 |
933 |
944 |
|
934 |
970 |
1,068 |
Barclaycard Consumer UK |
527 |
|
445 |
539 |
495 |
498 |
|
507 |
561 |
463 |
Wealth, Entrepreneurs & Business Banking |
372 |
|
405 |
387 |
392 |
399 |
|
387 |
412 |
412 |
Total income |
1,788 |
|
1,870 |
1,852 |
1,820 |
1,841 |
|
1,828 |
1,943 |
1,943 |
|
|
|
|
|
|
|
|
|
|
|
Analysis of credit impairment (charges)/releases and other provisions |
|
|
|
|
|
|
|
|
|
|
Personal Banking |
(76) |
|
(56) |
(60) |
(56) |
(50) |
|
(50) |
(47) |
(44) |
Barclaycard Consumer UK |
(113) |
|
(124) |
(145) |
(149) |
(123) |
|
(118) |
(291) |
(169) |
Wealth, Entrepreneurs & Business Banking |
(12) |
|
(4) |
4 |
(15) |
(5) |
|
(12) |
(12) |
(7) |
Total credit impairment charges and other provisions |
(201) |
|
(184) |
(201) |
(220) |
(178) |
|
(180) |
(350) |
(220) |
|
|
|
|
|
|
|
|
|
|
|
Analysis of loans and advances to customers at amortised cost |
£bn |
|
£bn |
£bn |
£bn |
£bn |
|
£bn |
£bn |
£bn |
Personal Banking |
140.5 |
|
139.8 |
138.4 |
136.5 |
134.4 |
|
135.0 |
135.3 |
134.7 |
Barclaycard Consumer UK |
15.2 |
|
16.4 |
16.3 |
16.2 |
16.1 |
|
16.5 |
16.2 |
16.2 |
Wealth, Entrepreneurs & Business Banking |
28.6 |
|
27.6 |
27.5 |
13.9 |
14.0 |
|
14.9 |
15.1 |
15.1 |
Total loans and advances to customers at amortised cost |
184.3 |
|
183.8 |
182.2 |
166.6 |
164.5 |
|
166.4 |
166.6 |
166.0 |
|
|
|
|
|
|
|
|
|
|
|
Analysis of customer deposits at amortised cost |
|
|
|
|
|
|
|
|
|
|
Personal Banking |
141.4 |
|
141.1 |
140.1 |
138.5 |
137.3 |
|
139.3 |
137.2 |
134.8 |
Barclaycard Consumer UK |
- |
|
- |
- |
- |
- |
|
- |
- |
- |
Wealth, Entrepreneurs & Business Banking |
50.6 |
|
52.3 |
49.2 |
48.9 |
47.1 |
|
49.7 |
48.3 |
46.9 |
Total customer deposits at amortised cost |
192.0 |
|
193.4 |
189.3 |
187.4 |
184.4 |
|
189.0 |
185.5 |
181.7 |
Barclays International |
|
|
|
|
|
|
|
|
|
|
|
Q118 |
|
Q417 |
Q317 |
Q217 |
Q117 |
|
Q416 |
Q316 |
Q216 |
Income statement information |
£m |
|
£m |
£m |
£m |
£m |
|
£m |
£m |
£m |
Net interest income |
1,013 |
|
987 |
1,148 |
1,060 |
1,112 |
|
1,046 |
1,355 |
1,001 |
Net trading income |
1,416 |
|
935 |
815 |
1,039 |
1,182 |
|
1,131 |
1,074 |
1,130 |
Net fee, commission and other income |
1,379 |
|
1,397 |
1,352 |
1,511 |
1,844 |
|
1,415 |
1,422 |
1,908 |
Total income |
3,808 |
|
3,319 |
3,315 |
3,610 |
4,138 |
|
3,592 |
3,851 |
4,039 |
Credit impairment charges and other provisions |
(93) |
|
(386) |
(495) |
(279) |
(346) |
|
(426) |
(420) |
(240) |
Net operating income |
3,715 |
|
2,933 |
2,820 |
3,331 |
3,792 |
|
3,166 |
3,431 |
3,799 |
Operating expenses excluding UK bank levy and litigation and conduct |
(2,300) |
|
(2,428) |
(2,182) |
(2,276) |
(2,435) |
|
(2,497) |
(2,337) |
(2,074) |
UK bank levy |
- |
|
(265) |
- |
- |
- |
|
(284) |
- |
- |
Litigation and conduct1 |
(15) |
|
(255) |
(5) |
4 |
(13) |
|
(17) |
(17) |
(10) |
Operating expenses |
(2,315) |
|
(2,948) |
(2,187) |
(2,272) |
(2,448) |
|
(2,798) |
(2,354) |
(2,084) |
Other net income |
13 |
|
21 |
19 |
202 |
12 |
|
5 |
8 |
11 |
Profit before tax |
1,413 |
|
6 |
652 |
1,261 |
1,356 |
|
373 |
1,085 |
1,726 |
Attributable profit/(loss) |
973 |
|
(1,168) |
359 |
819 |
837 |
|
43 |
623 |
1,171 |
|
|
|
|
|
|
|
|
|
|
|
Balance sheet information |
£bn |
|
£bn |
£bn |
£bn |
£bn |
|
£bn |
£bn |
£bn |
Loans and advances at amortised cost2 |
117.5 |
|
126.8 |
134.4 |
135.2 |
145.5 |
|
153.7 |
152.7 |
149.4 |
Trading portfolio assets |
114.9 |
|
113.0 |
91.2 |
83.3 |
83.0 |
|
73.2 |
73.8 |
68.1 |
Derivative financial instrument assets |
214.1 |
|
236.2 |
242.8 |
108.4 |
105.3 |
|
156.2 |
155.6 |
181.4 |
Derivative financial instrument liabilities |
210.8 |
|
237.8 |
242.9 |
116.8 |
112.8 |
|
160.6 |
160.5 |
187.5 |
Reverse repurchase agreements and other similar secured lending |
0.4 |
|
12.4 |
15.5 |
17.2 |
17.6 |
|
13.4 |
17.3 |
19.7 |
Financial assets at fair value through the income statement |
150.6 |
|
104.1 |
103.7 |
94.1 |
81.3 |
|
62.3 |
72.0 |
68.3 |
Total assets |
866.6 |
|
856.1 |
867.1 |
681.6 |
677.2 |
|
648.5 |
681.9 |
679.9 |
Deposits at amortised cost2 |
167.2 |
|
187.3 |
191.9 |
192.0 |
189.4 |
|
184.7 |
175.7 |
175.0 |
Loan: deposit ratio3 |
70% |
|
68% |
70% |
70% |
77% |
|
83% |
87% |
85% |
Risk weighted assets |
214.2 |
|
210.3 |
218.2 |
212.2 |
214.3 |
|
212.7 |
214.6 |
209.3 |
Period end allocated tangible equity |
30.0 |
|
27.5 |
28.0 |
26.8 |
27.1 |
|
25.6 |
25.9 |
25.3 |
|
|
|
|
|
|
|
|
|
|
|
Performance measures |
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity |
13.4% |
|
(15.9%) |
5.4% |
12.4% |
12.5% |
|
1.0% |
10.0% |
19.2% |
Average allocated tangible equity (£bn) |
30.1 |
|
28.5 |
28.9 |
27.4 |
27.7 |
|
26.6 |
25.7 |
24.8 |
Cost: income ratio |
61% |
|
89% |
66% |
63% |
59% |
|
78% |
61% |
52% |
Loan loss rate (bps) |
31 |
|
76 |
88 |
54 |
62 |
|
78 |
71 |
41 |
Net interest margin |
4.57% |
|
4.31% |
4.21% |
4.07% |
4.06% |
|
3.91% |
4.21% |
3.92% |
|
|
|
|
|
|
|
|
|
|
|
Performance measures excluding litigation and conduct1 |
£m |
|
£m |
£m |
£m |
£m |
|
£m |
£m |
£m |
Profit before tax |
1,428 |
|
261 |
657 |
1,257 |
1,369 |
|
390 |
1,102 |
1,736 |
Attributable profit/(loss) |
985 |
|
(918) |
363 |
816 |
846 |
|
57 |
640 |
1,181 |
Return on average allocated tangible equity |
13.6% |
|
(12.4%) |
5.5% |
12.3% |
12.6% |
|
1.2% |
10.3% |
19.3% |
Cost: income ratio |
60% |
|
81% |
66% |
63% |
59% |
|
77% |
61% |
51% |
1 |
Refer to pages 29-33 for further information and calculations of performance measures excluding litigation and conduct. |
2 |
Loans and advances at amortised cost have been restated to exclude cash collateral and settlement balances. Deposits at amortised cost have been restated to include deposits from banks and customers at amortised cost, and exclude cash collateral and settlement balances. |
3 |
Loan: deposit ratio is calculated as loans and advances at amortised cost divided by deposits at amortised cost. Comparatives have been restated based on this approach. |
Analysis of Barclays International |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate and Investment Bank |
Q118 |
|
Q417 |
Q317 |
Q217 |
Q117 |
|
Q416 |
Q316 |
Q216 |
Income statement information |
£m |
|
£m |
£m |
£m |
£m |
|
£m |
£m |
£m |
FICC1 |
869 |
|
607 |
627 |
752 |
889 |
|
766 |
947 |
881 |
Equities |
590 |
|
362 |
350 |
455 |
462 |
|
410 |
461 |
406 |
Markets |
1,459 |
|
969 |
977 |
1,207 |
1,351 |
|
1,176 |
1,408 |
1,287 |
Banking fees |
683 |
|
605 |
607 |
674 |
726 |
|
650 |
644 |
622 |
Corporate lending |
240 |
|
269 |
277 |
278 |
269 |
|
303 |
284 |
312 |
Transaction banking |
414 |
|
408 |
419 |
404 |
398 |
|
401 |
458 |
390 |
Banking |
1,337 |
|
1,282 |
1,303 |
1,356 |
1,393 |
|
1,354 |
1,386 |
1,324 |
Other |
3 |
|
1 |
- |
1 |
38 |
|
1 |
1 |
- |
Total income |
2,799 |
|
2,252 |
2,280 |
2,564 |
2,782 |
|
2,531 |
2,795 |
2,611 |
Credit impairment releases/(charges) and other provisions |
159 |
|
(127) |
(36) |
1 |
(51) |
|
(90) |
(38) |
(37) |
Operating expenses |
(1,786) |
|
(2,384) |
(1,661) |
(1,756) |
(1,941) |
|
(2,287) |
(1,872) |
(1,665) |
Other net income |
3 |
|
7 |
10 |
116 |
- |
|
1 |
- |
- |
Profit/(loss) before tax |
1,175 |
|
(252) |
593 |
925 |
790 |
|
155 |
885 |
909 |
|
|
|
|
|
|
|
|
|
|
|
Balance sheet information |
£bn |
|
£bn |
£bn |
£bn |
£bn |
|
£bn |
£bn |
£bn |
Loans and advances at amortised cost2 |
81.3 |
|
88.2 |
95.4 |
96.7 |
106.8 |
|
114.0 |
115.9 |
114.0 |
Deposits at amortised cost2 |
107.6 |
|
128.0 |
133.4 |
134.1 |
131.0 |
|
134.0 |
126.7 |
127.4 |
Risk weighted assets |
181.3 |
|
176.2 |
185.2 |
178.9 |
180.6 |
|
178.6 |
182.5 |
178.4 |
|
|
|
|
|
|
|
|
|
|
|
Performance measures |
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity |
13.0% |
|
(20.2%) |
5.9% |
11.1% |
8.2% |
|
(1.2%) |
9.2% |
9.5% |
Average allocated tangible equity (£bn) |
25.6 |
|
24.3 |
24.8 |
23.3 |
23.5 |
|
22.6 |
21.9 |
21.3 |
|
|
|
|
|
|
|
|
|
|
|
Consumer, Cards and Payments |
|
|
|
|
|
|
|
|
|
|
Income statement information |
£m |
|
£m |
£m |
£m |
£m |
|
£m |
£m |
£m |
Total income |
1,009 |
|
1,067 |
1,035 |
1,046 |
1,356 |
|
1,061 |
1,056 |
1,428 |
Credit impairment charges and other provisions |
(252) |
|
(259) |
(459) |
(280) |
(295) |
|
(336) |
(382) |
(203) |
Operating expenses |
(529) |
|
(564) |
(526) |
(516) |
(507) |
|
(511) |
(482) |
(419) |
Other net income |
10 |
|
14 |
9 |
86 |
12 |
|
4 |
8 |
11 |
Profit before tax |
238 |
|
258 |
59 |
336 |
566 |
|
218 |
200 |
817 |
|
|
|
|
|
|
|
|
|
|
|
Balance sheet information |
£bn |
|
£bn |
£bn |
£bn |
£bn |
|
£bn |
£bn |
£bn |
Loans and advances at amortised cost2 |
36.2 |
|
38.6 |
39.0 |
38.5 |
38.7 |
|
39.7 |
36.8 |
35.4 |
Deposits at amortised cost2 |
59.6 |
|
59.3 |
58.5 |
57.9 |
58.4 |
|
50.7 |
49.0 |
47.6 |
Risk weighted assets |
32.9 |
|
34.1 |
33.0 |
33.3 |
33.7 |
|
34.1 |
32.1 |
30.9 |
|
|
|
|
|
|
|
|
|
|
|
Performance measures |
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity |
15.6% |
|
8.9% |
2.2% |
19.4% |
36.4% |
|
13.2% |
14.8% |
77.9% |
Average allocated tangible equity (£bn) |
4.5 |
|
4.2 |
4.2 |
4.1 |
4.2 |
|
4.0 |
3.7 |
3.5 |
1 |
Fixed income, currencies and commodities (FICC) is composed of Credit and Macro income which were previously reported separately. |
2 |
Loans and advances at amortised cost have been restated to exclude cash collateral and settlement balances. Deposits at amortised cost have been restated to include deposits from banks and customers at amortised cost, and exclude cash collateral and settlement balances. |
Head Office |
|
|
|
|
|
|
|
|
|
|
|
Q118 |
|
Q417 |
Q317 |
Q217 |
Q117 |
|
Q416 |
Q316 |
Q216 |
Income statement information |
£m |
|
£m |
£m |
£m |
£m |
|
£m |
£m |
£m |
Net interest income |
(318) |
|
(254) |
(174) |
108 |
(115) |
|
29 |
(206) |
14 |
Net fee, commission and other income1 |
80 |
|
87 |
180 |
(24) |
33 |
|
(38) |
17 |
320 |
Total income |
(238) |
|
(167) |
6 |
84 |
(82) |
|
(9) |
(189) |
334 |
Credit impairment releases/(charges) and other provisions |
6 |
|
(3) |
(13) |
(1) |
- |
|
- |
1 |
(2) |
Net operating (expenses)/income |
(232) |
|
(170) |
(7) |
83 |
(82) |
|
(9) |
(188) |
332 |
Operating expenses excluding UK bank levy and litigation and conduct |
(59) |
|
(76) |
(112) |
(40) |
(49) |
|
15 |
(29) |
(36) |
UK bank levy |
- |
|
(41) |
- |
- |
- |
|
(2) |
- |
- |
Litigation and conduct2 |
(1,535) |
|
(75) |
(65) |
(1) |
(10) |
|
(1) |
(8) |
(11) |
Operating expenses |
(1,594) |
|
(192) |
(177) |
(41) |
(59) |
|
12 |
(37) |
(47) |
Other net income/(expenses) |
7 |
|
(3) |
(22) |
(164) |
- |
|
159 |
(4) |
(28) |
(Loss)/profit before tax |
(1,819) |
|
(365) |
(206) |
(122) |
(141) |
|
162 |
(229) |
257 |
Attributable (loss)/profit |
(1,699) |
|
(371) |
(199) |
(175) |
(123) |
|
223 |
(203) |
182 |
|
|
|
|
|
|
|
|
|
|
|
Balance sheet information |
£bn |
|
£bn |
£bn |
£bn |
£bn |
|
£bn |
£bn |
£bn |
Total assets |
40.4 |
|
39.7 |
51.7 |
17.3 |
74.5 |
|
75.2 |
73.3 |
87.7 |
Risk weighted assets3 |
31.2 |
|
31.8 |
36.1 |
26.2 |
52.9 |
|
53.3 |
47.5 |
43.2 |
Period end allocated tangible equity |
3.0 |
|
10.0 |
10.4 |
9.0 |
8.8 |
|
9.7 |
6.9 |
7.1 |
|
|
|
|
|
|
|
|
|
|
|
Performance measures |
|
|
|
|
|
|
|
|
|
|
Average allocated tangible equity (£bn) |
4.3 |
|
10.0 |
10.5 |
8.8 |
7.6 |
|
7.2 |
7.4 |
6.6 |
|
|
|
|
|
|
|
|
|
|
|
Performance measures excluding litigation and conduct2 |
£m |
|
£m |
£m |
£m |
£m |
|
£m |
£m |
£m |
(Loss)/profit before tax |
(284) |
|
(290) |
(141) |
(121) |
(131) |
|
163 |
(221) |
268 |
Attributable (loss)/profit |
(192) |
|
(307) |
(134) |
(174) |
(116) |
|
224 |
(195) |
189 |
1 |
Following the early adoption of the own credit provisions of IFRS 9 on 1 January 2017, own credit, which was previously reported in net fee, commission and other income, is recognised within other comprehensive income from Q117. |
2 |
Refer to pages 29-33 for further information and calculations of performance measures excluding litigation and conduct. |
3 |
Includes Africa Banking RWAs of £6.4bn (December 2017: £6.4bn). |
Performance Management
Margins and balances |
|
|
|
|
|
|
|
|
Three months ended 31.03.18 |
|
Three months ended 31.03.17 |
||||
|
Net interest income |
Average customer assets |
Net interest margin |
|
Net interest income |
Average customer assets |
Net interest margin |
|
£m |
£m |
% |
|
£m |
£m |
% |
Barclays UK |
1,493 |
185,351 |
3.27 |
|
1,511 |
166,065 |
3.69 |
Barclays International1 |
1,065 |
94,530 |
4.57 |
|
1,121 |
112,060 |
4.06 |
Total Barclays UK and Barclays International |
2,558 |
279,881 |
3.71 |
|
2,632 |
278,125 |
3.84 |
Other2 |
(370) |
|
|
|
(113) |
|
|
Total Barclays Group3 |
2,188 |
|
|
|
2,519 |
|
|
1 |
Barclays International margins include interest earning lending balances within the investment banking business. |
2 |
Other includes Head Office and non-interest earning lending balances within the investment banking business. Barclays Non-Core is included in the comparative period. |
3 |
Group net interest income includes net structural hedge contributions of £0.2bn (Q117: £0.4bn). |
Quarterly analysis for Barclays UK and Barclays International |
|
|
|
Net interest income |
Average customer assets |
Net interest margin |
|
Three months ended 31.12.17 |
£m |
£m |
% |
Barclays UK |
1,540 |
184,058 |
3.32 |
Barclays International1 |
1,071 |
98,500 |
4.31 |
Total Barclays UK and Barclays International |
2,611 |
282,558 |
3.67 |
|
|
|
|
Three months ended 30.09.17 |
|
|
|
Barclays UK |
1,501 |
181,419 |
3.28 |
Barclays International1 |
1,070 |
100,828 |
4.21 |
Total Barclays UK and Barclays International |
2,571 |
282,247 |
3.61 |
|
|
|
|
Three months ended 30.06.17 |
|
|
|
Barclays UK |
1,534 |
166,345 |
3.70 |
Barclays International1 |
1,064 |
104,899 |
4.07 |
Total Barclays UK and Barclays International |
2,598 |
271,244 |
3.84 |
|
|
|
|
Three months ended 31.03.17 |
|
|
|
Barclays UK |
1,511 |
166,065 |
3.69 |
Barclays International1 |
1,121 |
112,060 |
4.06 |
Total Barclays UK and Barclays International |
2,632 |
278,125 |
3.84 |
1 |
Barclays International margins include interest earning lending balances within the investment banking business. |
Credit Risk
Financial instruments subject to impairment |
|||||||
|
As at 31.03.18 |
|
As at 01.01.181 |
||||
|
Gross exposure2 |
Impairment allowance2 |
Net exposure |
|
Gross exposure2 |
Impairment allowance2 |
Net exposure |
|
£m |
£m |
£m |
|
£m |
£m |
£m |
Home loans |
147,514 |
468 |
147,046 |
|
146,973 |
464 |
146,509 |
Cards, unsecured loans and other retail lending |
56,548 |
5,279 |
51,269 |
|
58,792 |
5,266 |
53,526 |
Corporate loans |
121,928 |
1,158 |
120,770 |
|
118,525 |
1,378 |
117,147 |
Loans and advances at amortised cost |
325,990 |
6,905 |
319,085 |
|
324,290 |
7,108 |
317,182 |
Off-balance sheet loan commitments and financial guarantee contracts |
331,720 |
252 |
331,468 |
|
334,573 |
420 |
334,153 |
Total |
657,710 |
7,157 |
650,553 |
|
658,863 |
7,528 |
651,335 |
1 |
Comparatives are as at 1 January 2018 to reflect the adoption of IFRS 9 from this date. |
2 |
Excludes gross exposure of £63.7bn (1 January 2018: £53.2bn) and impairment allowance of £4m (1 January 2018: £3m) on financial assets at fair value through other comprehensive income. |
Analysis of loans and advances at amortised cost and off-balance sheet exposures
|
As at 31.03.18 |
|
Three months ended 31.03.18 |
||||
|
Gross exposure |
Impairment allowance |
Net exposure |
Coverage ratio |
|
Impairment charge1 |
Loan loss rate |
|
£m |
£m |
£m |
% |
|
£m |
bps |
Barclays UK |
159,349 |
2,709 |
156,640 |
1.7 |
|
180 |
46 |
Barclays International |
29,277 |
2,583 |
26,694 |
8.8 |
|
251 |
348 |
Head Office |
8,626 |
362 |
8,264 |
4.2 |
|
9 |
42 |
Total Group retail |
197,252 |
5,654 |
191,598 |
2.9 |
|
440 |
90 |
Barclays UK |
28,279 |
231 |
28,048 |
0.8 |
|
21 |
30 |
Barclays International |
91,722 |
964 |
90,758 |
1.1 |
|
(158) |
(70) |
Head Office |
8,737 |
56 |
8,681 |
0.6 |
|
(16) |
(74) |
Total Group wholesale |
128,738 |
1,251 |
127,487 |
1.0 |
|
(153) |
(48) |
Total loans and advances at amortised cost |
325,990 |
6,905 |
319,085 |
2.1 |
|
287 |
36 |
Off-balance sheet loan commitments and financial guarantee contracts |
331,720 |
252 |
331,468 |
0.1 |
|
|
|
Total |
657,710 |
7,157 |
650,553 |
1.1 |
|
|
|
|
|
|
|
|
|
|
|
|
As at 01.01.182 |
|
|
|
|||
|
Gross exposure |
Impairment allowance |
Net exposure |
Coverage ratio |
|
|
|
|
£m |
£m |
£m |
% |
|
|
|
Barclays UK |
158,787 |
2,594 |
156,193 |
1.6 |
|
|
|
Barclays International |
30,944 |
2,676 |
28,268 |
8.6 |
|
|
|
Head Office |
9,046 |
364 |
8,682 |
4.0 |
|
|
|
Total Group retail |
198,777 |
5,634 |
193,143 |
2.8 |
|
|
|
Barclays UK |
27,807 |
227 |
27,580 |
0.8 |
|
|
|
Barclays International |
88,804 |
1,182 |
87,622 |
1.3 |
|
|
|
Head Office |
8,902 |
65 |
8,837 |
0.7 |
|
|
|
Total Group wholesale |
125,513 |
1,474 |
124,039 |
1.2 |
|
|
|
Total loans and advances at amortised cost |
324,290 |
7,108 |
317,182 |
2.2 |
|
|
|
Off-balance sheet loan commitments and financial guarantee contracts |
334,573 |
420 |
334,153 |
0.1 |
|
|
|
Total |
658,863 |
7,528 |
651,335 |
1.1 |
|
|
|
1 |
Includes impairment charges on loans and advances at amortised cost, and off-balance sheet loan commitments and financial guarantee contracts. Excludes impairment charge of £1m on financial assets at fair value through other comprehensive income. |
2 |
Comparatives are as at 1 January 2018 to reflect the adoption of IFRS 9 from this date. |
Treasury and Capital Risk
Capital ratios |
As at |
As at |
31.03.18 |
31.12.17 |
|
CET11 |
12.7% |
13.3% |
Tier 1 (T1) |
16.4% |
17.2% |
Total capital |
20.3% |
21.5% |
|
|
|
Capital resources |
£m |
£m |
Total equity excluding non-controlling interests per the balance sheet |
59,519 |
63,905 |
Less: other equity instruments (recognised as additional tier 1 (AT1) capital) |
(8,941) |
(8,941) |
Adjustment to retained earnings for foreseeable dividends |
(664) |
(392) |
|
|
|
Other regulatory adjustments and deductions: |
|
|
Additional value adjustments (PVA) |
(1,365) |
(1,385) |
Goodwill and intangible assets |
(7,858) |
(7,908) |
Deferred tax assets that rely on future profitability excluding temporary differences |
(525) |
(593) |
Fair value reserves related to gains or losses on cash flow hedges |
(709) |
(1,161) |
Excess of expected losses over impairment |
- |
(1,239) |
Gains or losses on liabilities at fair value resulting from own credit |
120 |
83 |
Defined benefit pension fund assets |
(565) |
(732) |
Direct and indirect holdings by an institution of own CET1 instruments |
(50) |
(50) |
Adjustment under IFRS 9 transitional arrangements |
1,314 |
- |
Other regulatory adjustments |
(30) |
(22) |
CET1 capital1 |
40,246 |
41,565 |
|
|
|
AT1 capital2 |
|
|
Capital instruments and related share premium accounts |
8,941 |
8,941 |
Qualifying AT1 capital (including minority interests) issued by subsidiaries |
3,053 |
3,538 |
Other regulatory adjustments and deductions |
(130) |
(130) |
AT1 capital |
11,864 |
12,349 |
|
|
|
T1 capital |
52,110 |
53,914 |
|
|
|
Tier 2 (T2) capital2 |
|
|
Capital instruments and related share premium accounts |
6,293 |
6,472 |
Qualifying T2 capital (including minority interests) issued by subsidiaries |
6,253 |
7,040 |
Credit risk adjustments (excess of impairment over expected losses) |
143 |
- |
Other regulatory adjustments and deductions |
(251) |
(251) |
Total regulatory capital |
64,548 |
67,175 |
|
|
|
Total RWAs1 |
317,946 |
313,033 |
1 |
CET1 capital and RWAs are calculated applying the IFRS 9 transitional arrangements under Article 473a of the CRR. For more information refer to the Barclays PLC Pillar 3 Report Q1 2018, located at home.barclays/results. |
2 |
AT1 and T2 capital are calculated applying the grandfathering of CRR non-compliant capital instruments. For further information on the relevant ratio for AT1 securities refer to the Barclays PLC Pillar 3 Report Q1 2018. |
Movement in CET1 capital |
Three months |
ended |
|
31.03.18 |
|
£m |
|
Opening CET1 capital |
41,565 |
|
|
Effects of changes in accounting policies |
(2,150) |
|
|
Loss for the period attributable to equity holders |
(593) |
Own credit relating to derivative liabilities |
(19) |
Dividends paid and foreseen |
(397) |
Decrease in retained regulatory capital generated from earnings |
(1,009) |
|
|
Net impact of share schemes |
(330) |
Fair value through other comprehensive income reserve |
64 |
Currency translation reserve |
(602) |
Other reserves |
23 |
Decrease in other qualifying reserves |
(845) |
|
|
Pension re-measurements within reserves |
(165) |
Defined benefit pension fund asset deduction |
167 |
Net impact of pensions |
2 |
|
|
Additional value adjustments (PVA) |
20 |
Goodwill and intangible assets |
50 |
Deferred tax assets that rely on future profitability excluding those arising from temporary differences |
68 |
Excess of expected loss over impairment |
1,239 |
Adjustment under IFRS 9 transitional arrangements |
1,314 |
Other regulatory adjustments |
(8) |
Increase in regulatory capital due to adjustments and deductions |
2,683 |
|
|
Closing CET1 capital |
40,246 |
CET1 capital decreased £1.3bn to £40.2bn due to the following significant movements:
• |
A £0.6bn loss for the period attributable to equity holders as organic capital generation from profits of £1.3bn was more than offset by litigation and conduct charges, which included a £1.4bn settlement relating to RMBS |
• |
A £0.4bn decrease due to dividends paid and foreseen |
• |
A £0.3bn decrease largely due to the purchase of share awards |
• |
A £0.6bn decrease in the currency translation reserve driven by the depreciation of period end USD against GBP |
The implementation of IFRS 9 resulted in a net increase in CET1 capital as the initial decrease in shareholders' equity of £2.2bn on implementation was more than offset by the transitional relief of £1.3bn and the removal of £1.2bn of regulatory deduction for the excess of expected loss over impairment.
The UK Retirement Fund, which is the Group's main pension scheme, was in an IAS 19 surplus position of £0.7bn (December 2017: £1.0bn). As a surplus position is deducted from capital, and as no deficit reduction contributions were made in the quarter, there was no impact from pensions on the CET1 ratio in the quarter.
Risk weighted assets (RWAs) by risk type and business |
|||||||||||||
|
Credit risk |
|
Counterparty credit risk |
|
Market risk |
|
Operational risk |
Total RWAs |
|||||
|
Std |
IRB |
|
Std |
IRB |
Settlement risk |
CVA |
|
Std |
IMA |
|
|
|
As at 31.03.18 |
£m |
£m |
|
£m |
£m |
£m |
£m |
|
£m |
£m |
|
£m |
£m |
Barclays UK |
3,245 |
57,113 |
|
- |
- |
- |
- |
|
- |
- |
|
12,167 |
72,525 |
Barclays International |
47,546 |
71,889 |
|
17,818 |
16,999 |
72 |
2,491 |
|
16,117 |
13,583 |
|
27,708 |
214,223 |
Head Office1 |
2,827 |
8,995 |
|
109 |
506 |
- |
230 |
|
102 |
1,644 |
|
16,785 |
31,198 |
Barclays Group |
53,618 |
137,997 |
|
17,927 |
17,505 |
72 |
2,721 |
|
16,219 |
15,227 |
|
56,660 |
317,946 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As at 31.12.17 |
|
|
|
|
|
|
|
|
|||||
Barclays UK |
3,811 |
54,955 |
|
- |
- |
- |
- |
|
- |
- |
|
12,167 |
70,933 |
Barclays International |
49,058 |
69,520 |
|
17,000 |
17,243 |
101 |
2,776 |
|
13,313 |
13,547 |
|
27,708 |
210,266 |
Head Office1 |
2,907 |
9,766 |
|
65 |
633 |
- |
225 |
|
88 |
1,365 |
|
16,785 |
31,834 |
Barclays Group |
55,776 |
134,241 |
|
17,065 |
17,876 |
101 |
3,001 |
|
13,401 |
14,912 |
|
56,660 |
313,033 |
1 |
Includes Africa Banking RWAs. |
Movement analysis of RWAs |
|||||
|
Credit risk |
Counterparty credit risk |
Market risk |
Operational risk |
Total RWAs |
Three months ended 31.03.18 |
£bn |
£bn |
£bn |
£bn |
£bn |
Opening RWAs |
190.0 |
38.0 |
28.3 |
56.7 |
313.0 |
Book size |
3.9 |
1.2 |
2.8 |
- |
7.9 |
Acquisitions and disposals |
- |
- |
- |
- |
- |
Book quality |
(0.7) |
(0.2) |
- |
- |
(0.9) |
Model updates |
(0.6) |
- |
- |
- |
(0.6) |
Methodology and policy |
0.9 |
(0.7) |
0.3 |
- |
0.5 |
Foreign exchange movements1 |
(1.9) |
- |
- |
- |
(1.9) |
Closing RWAs |
191.6 |
38.3 |
31.4 |
56.7 |
317.9 |
1 |
Foreign exchange movement does not include foreign exchange for counterparty credit risk or market risk. |
RWAs increased £4.9bn to £317.9bn:
• |
Book size increased RWAs £7.9bn primarily as a result of business growth, and increased derivatives portfolio and securities financing transaction trading activity in investment banking businesses |
• |
Foreign exchange movements decreased RWAs £1.9bn primarily due to the depreciation of period end USD against GBP |
Leverage ratio and exposures
Barclays is subject to a UK leverage ratio requirement that is implemented on a phased basis, with a transitional requirement of 3.6% as at 31 March 2018; this comprises the 3.25% minimum requirement, a transitional G-SII additional leverage ratio buffer (G-SII ALRB) of 0.39% and a countercyclical leverage ratio buffer (CCLB) which is currently nil. Although the leverage ratio is expressed in terms of tier 1 capital, 75% of the minimum requirement, equating to 2.4375%, needs to be met with CET1 capital. In addition, the G-SII ALRB and CCLB must be covered solely with CET1 capital. The CET1 capital held against the 0.39% transitional G-SII ALRB was £4.1bn. The fully loaded UK leverage requirement is expected to be 4.0%.
From Q118, following the end of the transitional period, Barclays is required to disclose an average UK leverage ratio which is based on capital on the last day of each month in the quarter and an exposure measure for each day in the quarter. During the transitional period, the exposure measure was based on the last day of each month in the quarter. Barclays is also required to disclose a UK leverage ratio based on capital and exposure on the last day of the quarter. Both approaches exclude qualifying claims on central banks from the leverage exposures.
|
As at 31.03.18 |
As at 31.12.17 |
Leverage ratios |
£bn |
£bn |
Average tier 1 capital1 |
50.0 |
51.2 |
Average UK leverage exposure2,3 |
1,090 |
1,045 |
Average UK leverage ratio |
4.6% |
4.9% |
UK leverage ratio |
4.8% |
5.1% |
|
|
|
CET1 capital |
40.2 |
41.6 |
AT1 capital |
8.8 |
8.8 |
Tier 1 capital1 |
49.1 |
50.4 |
|
|
|
Leverage exposure |
|
|
Accounting assets |
|
|
Derivative financial instruments |
215 |
238 |
Derivative cash collateral |
52 |
53 |
Securities financing transactions |
128 |
113 |
Loans and advances and other assets |
747 |
729 |
Total IFRS assets |
1,142 |
1,133 |
|
|
|
Regulatory consolidation adjustments |
8 |
8 |
|
|
|
Derivatives adjustments |
|
|
Derivatives netting |
(195) |
(217) |
Adjustments to cash collateral |
(34) |
(42) |
Net written credit protection |
18 |
14 |
Potential future exposure (PFE) on derivatives |
121 |
120 |
Total derivatives adjustments |
(90) |
(125) |
|
|
|
Securities financing transactions (SFTs) adjustments |
20 |
19 |
|
|
|
Regulatory deductions and other adjustments |
(10) |
(13) |
|
|
|
Weighted off-balance sheet commitments |
101 |
103 |
|
|
|
Qualifying central bank claims |
(140) |
(140) |
|
|
|
UK leverage exposure3 |
1,031 |
985 |
1 |
The tier 1 capital is calculated in line with the PRA Handbook, which excludes grandfathered AT1 instruments allowed under CRR. |
2 |
The average UK leverage exposure as at 31 December 2017 was calculated based on the last day of each month in the quarter. |
3 |
Capital and leverage measures are calculated applying the IFRS 9 transitional arrangements under Article 473a of the CRR. For more information refer to the Barclays PLC Pillar 3 Report Q1 2018, located at home.barclays/results. |
The average UK leverage ratio decreased to 4.6% (December 2017: 4.9%) partially driven by the change to the daily exposure measure. Average UK leverage exposures increased due to higher trading activity in SFTs and trading portfolio assets. Tier 1 capital decreased, primarily due to settlement of litigation and conduct charges.
The UK leverage ratio decreased to 4.8% (December 2017: 5.1%) due to a decrease in the tier 1 capital to £49.1bn (December 2017: £50.4bn) primarily driven by £2.0bn of litigation and conduct charges and an increase in UK leverage exposure to £1,031bn (December 2017: £985bn).
• |
Loans and advances and other assets increased £18bn to £747bn primarily driven by a £11bn increase in holdings of government securities and a £10bn increase in settlement balances, offset by a £14bn decrease in cash and balances at central banks held as part of the Group liquidity pool |
• |
SFTs increased £15bn to £128bn primarily driven by matched book trading activity |
• |
Net derivative leverage exposures, excluding net written credit protection and PFE on derivatives, increased £6bn to £38bn primarily driven by reduced collateral netting |
The difference between the average UK leverage ratio and the UK leverage ratio was primarily driven by lower SFTs, trading portfolio assets and settlement exposures at quarter end.
Barclays is also required to disclose a CRR leverage ratio. This is included in the additional Barclays regulatory disclosures, prepared in accordance with European Banking Authority (EBA) guidelines on disclosure requirements under Part Eight of Regulation (EU) No 575/2013 (see Barclays PLC Pillar 3 Report Q1 2018), which will be disclosed on 26 April 2018, available at home.barclays/results.
Minimum requirement for own funds and eligible liabilities (MREL)
Under the Bank of England's statement of policy on MREL, the Bank of England will set MREL for UK Global Systemically Important Banks (G-SIBs) as necessary to implement the total loss-absorbing capacity (TLAC) standard. Institution or group-specific MREL requirements will depend on the preferred resolution strategy for that institution or group.
The MREL requirements will be phased in from 1 January 2019 and will be fully implemented by 1 January 2022, at which time G-SIBs with resolution entities incorporated in the UK, including Barclays, will be required to meet an MREL equivalent to the higher of either: (i) two times the sum of its Pillar 1 and Pillar 2A requirements or; (ii) the higher of two times its leverage ratio or 6.75% of leverage exposures. However, the PRA will review the MREL calibration by the end of 2020, including assessing the proposal for Pillar 2A recapitalisation which may drive a different 1 January 2022 MREL requirement than currently proposed. In addition, it is proposed that CET1 capital cannot be counted towards both MREL and the combined buffer requirement (CBR), meaning that the CBR will effectively be applied above both the Pillar 1 and Pillar 2A requirements relating to own funds and MREL.
Barclays' indicative MREL requirement is currently expected to be 29.1% of RWAs from 1 January 2022 consisting of the following components:
· |
Loss absorption and recapitalisation amounts consisting of 8% Pillar 1 and 4.3% Pillar 2A buffers |
· |
Regulatory buffers including a 1.5% G-SII buffer, 2.5% CCB and 0.5% from the planned introduction of a 1% CCyB for the UK1 |
MREL ratios and position |
|
|
|
|
|
MREL ratios |
As at 31.03.18 |
As at 31.12.17 |
CET1 capital2 |
12.7% |
13.3% |
AT1 capital instruments and related share premium accounts |
2.8% |
2.9% |
T2 capital instruments and related share premium accounts |
2.0% |
2.1% |
Term senior unsecured funding |
7.2% |
6.8% |
Total Barclays PLC (the Parent company) MREL ratio |
24.7% |
25.0% |
Qualifying AT1 capital (including minority interests) issued by subsidiaries3 |
0.9% |
1.1% |
Qualifying T2 capital (including minority interests) issued by subsidiaries3 |
1.9% |
2.2% |
Total MREL ratio including eligible BBPLC instruments |
27.5% |
28.2% |
|
|
|
MREL position |
£m |
£m |
CET1 capital2 |
40,246 |
41,565 |
AT1 capital instruments and related share premium accounts |
8,941 |
8,941 |
T2 capital instruments and related share premium accounts |
6,293 |
6,472 |
Term senior unsecured funding |
22,921 |
21,166 |
Total Barclays PLC (the Parent company) MREL position |
78,401 |
78,144 |
Qualifying AT1 capital (including minority interests) issued by subsidiaries3 |
2,923 |
3,408 |
Qualifying T2 capital (including minority interests) issued by subsidiaries3 |
6,145 |
6,789 |
Total MREL position including eligible BBPLC instruments |
87,469 |
88,341 |
|
|
|
Total RWAs2 |
317,946 |
313,033 |
1 |
2022 requirements subject to Bank of England review by the end of 2020. |
2 |
CET1 capital and RWAs are calculated applying IFRS 9 transitional arrangements under Article 473a of the CRR. |
3 |
Includes other AT1 capital regulatory adjustments and deductions of £130m (December 2017: £130m) and T2 credit risk adjustments and other regulatory adjustments and deductions of £108m (December 2017: £251m). |
Condensed Consolidated Financial Statements
Consolidated summary income statement |
|
|
|
Three months ended |
Three months ended |
|
31.03.18 |
31.03.17 |
|
£m |
£m |
Total income |
5,358 |
5,823 |
Credit impairment charges and other provisions |
(288) |
(527) |
Net operating income |
5,070 |
5,296 |
Operating expenses excluding litigation and conduct |
(3,364) |
(3,591) |
Litigation and conduct |
(1,961) |
(28) |
Operating expenses |
(5,325) |
(3,619) |
Other net income |
19 |
5 |
(Loss)/profit before tax |
(236) |
1,682 |
Tax charge |
(304) |
(473) |
(Loss)/profit after tax in respect of continuing operations |
(540) |
1,209 |
Loss after tax in respect of discontinued operation |
- |
(658) |
(Loss)/profit after tax |
(540) |
551 |
|
|
|
Attributable to: |
|
|
Ordinary equity holders of the parent |
(764) |
190 |
Other equity instrument holders1 |
171 |
139 |
Total equity holders |
(593) |
329 |
Non-controlling interests in respect of continuing operations |
53 |
79 |
Non-controlling interests in respect of discontinued operation |
- |
143 |
(Loss)/profit after tax |
(540) |
551 |
|
|
|
Earnings per share |
|
|
Basic (loss)/earnings per ordinary share1 |
(4.2p) |
1.3p |
Basic (loss)/earnings per ordinary share in respect of continuing operations1 |
(4.2p) |
6.1p |
Basic loss per ordinary share in respect of discontinued operation |
- |
(4.8p) |
1 |
The profit after tax attributable to other equity instrument holders of £171m (Q117: £139m) is offset by a tax credit recorded in reserves of £46m (Q117: £38m). The net amount of £125m (Q117: £101m), along with non-controlling interests, is deducted from profit after tax in order to calculate earnings per share and return on average tangible shareholders' equity. |
Consolidated summary balance sheet |
|
|
|
As at |
As at |
|
31.03.18 |
01.01.181 |
Assets |
£m |
£m |
Cash and balances at central banks |
157,332 |
171,082 |
Cash collateral and settlement balances |
86,714 |
74,779 |
Loans and advances at amortised cost |
319,085 |
317,182 |
Reverse repurchase agreements and other similar secured lending |
1,082 |
597 |
Trading portfolio assets |
115,819 |
114,173 |
Financial assets at fair value through the income statement |
160,341 |
140,211 |
Derivative financial instruments |
215,215 |
237,669 |
Financial assets at fair value through other comprehensive income |
63,745 |
53,241 |
Investments in associates and joint ventures |
700 |
699 |
Goodwill and intangible assets |
7,806 |
7,849 |
Current tax assets |
506 |
482 |
Deferred tax assets |
4,196 |
4,084 |
Other assets |
8,702 |
8,200 |
Assets included in disposal groups classified as held for sale |
957 |
1,193 |
Total assets |
1,142,200 |
1,131,441 |
|
|
|
Liabilities |
|
|
Deposits at amortised cost |
381,326 |
379,841 |
Cash collateral and settlement balances |
74,113 |
65,925 |
Repurchase agreements and other similar secured borrowing |
18,610 |
15,053 |
Debt securities in issue |
79,035 |
73,314 |
Subordinated liabilities |
21,004 |
23,826 |
Trading portfolio liabilities |
45,333 |
37,351 |
Financial liabilities designated at fair value |
234,287 |
220,083 |
Derivative financial instruments |
211,800 |
238,345 |
Current tax liabilities |
787 |
586 |
Deferred tax liabilities |
41 |
44 |
Other liabilities |
14,234 |
13,207 |
Total liabilities |
1,080,570 |
1,067,575 |
|
|
|
Equity |
|
|
Called up share capital and share premium |
22,061 |
22,045 |
Other reserves |
4,201 |
5,247 |
Retained earnings |
24,316 |
25,522 |
Shareholders' equity attributable to ordinary shareholders of the parent |
50,578 |
52,814 |
Other equity instruments |
8,941 |
8,941 |
Total equity excluding non-controlling interests |
59,519 |
61,755 |
Non-controlling interests |
2,111 |
2,111 |
Total equity |
61,630 |
63,866 |
|
|
|
Total liabilities and equity |
1,142,200 |
1,131,441 |
1 |
Barclays introduced changes to the balance sheet presentation as a result of the adoption of new accounting policies on 1 January 2018. The comparatives are presented under the new accounting policies to aid comparability. A reconciliation of the statutory balance sheet as at 31 December 2017 to 1 January 2018 is on pages 24-25. |
Consolidated statement of changes in equity |
|||||||
|
Called up share capital and share premium |
Other equity instruments |
Other reserves |
Retained earnings |
Total |
Non-controlling interests |
Total equity |
Three months ended 31.03.18 |
£m |
£m |
£m |
£m |
£m |
£m |
£m |
Balance as at 31 December 2017 |
22,045 |
8,941 |
5,383 |
27,536 |
63,905 |
2,111 |
66,016 |
Effects of changes in accounting policies1 |
- |
- |
(136) |
(2,014) |
(2,150) |
- |
(2,150) |
Balance as at 1 January 2018 |
22,045 |
8,941 |
5,247 |
25,522 |
61,755 |
2,111 |
63,866 |
Profit after tax |
- |
171 |
- |
(764) |
(593) |
53 |
(540) |
Other comprehensive profit after tax for the period |
- |
- |
(1,046) |
(158) |
(1,204) |
- |
(1,204) |
Total comprehensive income for the period |
- |
171 |
(1,046) |
(922) |
(1,797) |
53 |
(1,744) |
Issue of shares under employee share schemes |
16 |
- |
- |
132 |
148 |
- |
148 |
Coupons paid on other equity instruments |
- |
(171) |
- |
46 |
(125) |
- |
(125) |
Treasury shares |
- |
- |
- |
(478) |
(478) |
- |
(478) |
Dividends |
- |
- |
- |
- |
- |
(52) |
(52) |
Other movements |
- |
- |
- |
16 |
16 |
(1) |
15 |
Balance as at 31 March 2018 |
22,061 |
8,941 |
4,201 |
24,316 |
59,519 |
2,111 |
61,630 |
|
As at |
As at |
|
31.03.18 |
01.01.181 |
Other reserves |
£m |
£m |
Currency translation reserve |
2,452 |
3,054 |
Fair value through other comprehensive income reserve |
292 |
228 |
Cash flow hedging reserve |
709 |
1,161 |
Own credit reserve |
(235) |
(179) |
Other reserves and treasury shares |
983 |
983 |
Total other reserves |
4,201 |
5,247 |
1 |
Barclays introduced changes to the balance sheet presentation as a result of the adoption of new accounting policies on 1 January 2018. The comparatives are presented under the new accounting policies to aid comparability. A reconciliation of the statutory balance sheet as at 31 December 2017 to 1 January 2018 is on pages 24-25. |
Balance sheet movements
The table below presents the impact of the changes to balance sheet presentation, the transition to IFRS 15 and the transition to IFRS 9 on the Group's balance sheet, showing separately the changes arising from reclassification and any associated remeasurement, and the impact of increased impairment.
|
As at 31.12.17 |
Balance sheet presentation and IFRS 15 |
IFRS 9 classification and measurement |
IFRS 9 impairment change |
As at 01.01.18 |
Assets |
£m |
£m |
£m |
£m |
£m |
Cash and balances at central banks |
171,082 |
- |
- |
- |
171,082 |
Items in the course of collection from other banks |
2,153 |
(2,153) |
- |
- |
- |
Loans and advances to banks |
35,663 |
(35,663) |
- |
- |
- |
Loans and advances to customers |
365,552 |
(365,552) |
- |
- |
- |
Cash collateral and settlement balances |
- |
77,168 |
(2,389) |
- |
74,779 |
Loans and advances at amortised cost |
- |
329,157 |
(9,467) |
(2,508) |
317,182 |
Reverse repurchase agreements and other similar secured lending |
12,546 |
- |
(11,949) |
- |
597 |
Trading portfolio assets |
113,760 |
- |
413 |
- |
114,173 |
Financial assets designated at fair value |
116,281 |
(116,281) |
- |
- |
- |
Financial assets at fair value through the income statement1 |
- |
116,281 |
23,930 |
- |
140,211 |
Derivative financial instruments |
237,669 |
- |
- |
- |
237,669 |
Financial investments |
58,916 |
(57,415) |
(1,501) |
- |
- |
Financial assets at fair value through other comprehensive income |
- |
52,305 |
936 |
- |
53,241 |
Investments in associates and joint ventures2 |
718 |
- |
(19) |
- |
699 |
Goodwill and intangible assets |
7,849 |
- |
- |
- |
7,849 |
Current tax assets |
482 |
- |
- |
- |
482 |
Deferred tax assets |
3,457 |
(22) |
- |
649 |
4,084 |
Prepayments, accrued income and other assets |
5,927 |
(5,927) |
- |
- |
- |
Other assets |
- |
8,169 |
31 |
- |
8,200 |
Assets included in disposal groups classified as held for sale |
1,193 |
- |
- |
- |
1,193 |
Total assets |
1,133,248 |
67 |
(15) |
(1,859) |
1,131,441 |
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
Deposits from banks |
37,723 |
(37,723) |
- |
- |
- |
Deposits at amortised cost |
- |
398,701 |
(18,860) |
- |
379,841 |
Items in the course of collection due to other banks |
446 |
(446) |
- |
- |
- |
Customer accounts |
429,121 |
(429,121) |
- |
- |
- |
Cash collateral and settlement balances |
- |
68,143 |
(2,218) |
- |
65,925 |
Repurchase agreements and other similar secured borrowing |
40,338 |
- |
(25,285) |
- |
15,053 |
Debt securities in issue |
73,314 |
- |
- |
- |
73,314 |
Subordinated liabilities |
23,826 |
- |
- |
- |
23,826 |
Trading portfolio liabilities |
37,351 |
- |
- |
- |
37,351 |
Financial liabilities designated at fair value |
173,718 |
- |
46,365 |
- |
220,083 |
Derivative financial instruments |
238,345 |
- |
- |
- |
238,345 |
Current tax liabilities |
586 |
- |
- |
- |
586 |
Deferred tax liabilities |
44 |
- |
- |
- |
44 |
Accruals, deferred income and other liabilities |
12,420 |
(12,420) |
- |
- |
- |
Other liabilities |
- |
12,866 |
- |
341 |
13,207 |
Total liabilities |
1,067,232 |
- |
2 |
341 |
1,067,575 |
|
|
|
|
|
|
Equity |
|
|
|
|
|
Called up share capital and share premium |
22,045 |
- |
- |
- |
22,045 |
Other reserves |
5,383 |
- |
(139) |
3 |
5,247 |
Retained earnings |
27,536 |
67 |
122 |
(2,203) |
25,522 |
Shareholders' equity attributable to ordinary shareholders of the parent |
54,964 |
67 |
(17) |
(2,200) |
52,814 |
Other equity instruments |
8,941 |
- |
- |
- |
8,941 |
Total equity excluding non-controlling interests |
63,905 |
67 |
(17) |
(2,200) |
61,755 |
Non-controlling interests |
2,111 |
- |
- |
- |
2,111 |
Total equity |
66,016 |
67 |
(17) |
(2,200) |
63,866 |
|
|
|
|
|
|
Total liabilities and equity |
1,133,248 |
67 |
(15) |
(1,859) |
1,131,441 |
1 |
Financial assets at fair value through the income statement includes both designated and mandatory fair value assets. |
2 |
The impact of IFRS 9 on the Group's share of profit and loss from joint ventures is shown in the classification and measurement column. |
Balance sheet presentation and IFRS 15
The following changes to the balance sheet have been introduced:
· |
"Items in the course of collection from other banks" and "prepayments, accrued income and other assets" are reported in "other assets". Equally, "items in the course of collection due to other banks" and "accruals, deferred income and other liabilities" are reported in "other liabilities" |
· |
"Loans and advances to banks" and "loans and advances to customers" have been disaggregated to "loans and advances at amortised cost" and "cash collateral and settlement balances". Equally, "deposits from banks" and "customer accounts" have been disaggregated to "deposits at amortised cost" and "cash collateral and settlement balances" |
· |
"Financial assets designated at fair value" have moved to "financial assets at fair value through the income statement" on adoption of IFRS 9 |
· |
The majority of "available for sale assets" have moved to "financial assets at fair value through other comprehensive income" from "financial investments" on adoption of IFRS 9. In addition, "held to maturity assets" have moved to "loans and advances at amortised cost" |
· |
On adoption of IFRS 15, a transition adjustment of £67m has been recognised through retained earnings |
IFRS 9 classification and measurement
This column represents the changes to the balance sheet from classification and measurement. The net effect is a decrease in shareholders' equity of £17m, with no significant offsetting movements. The classification changes include the transfer of certain Barclays International Prime Services and Equities positions from an amortised cost to a fair value approach.
IFRS 9 impairment change
Additional impairment from the adoption of IFRS 9 is shown in the impairment change column. The increase in impairment results in the recognition of a deferred tax asset that will amortise to current tax over time. The post-tax impact is a reduction in shareholders' equity of £2.2bn. Impairment allowance under IFRS 9 considers both the drawn and the undrawn counterparty exposure. For retail portfolios, the total impairment allowance is allocated to the drawn exposure to the extent that the allowance does not exceed the exposure. Any excess is reported on the liability side of the balance sheet as a provision. For wholesale portfolios the impairment allowance on the undrawn exposure is reported on the liability side of the balance sheet as a provision.
For further details, refer to the Barclays PLC IFRS 9 Transition Note at home.barclays/results.
Barclays PLC Parent Company
Summary balance sheet |
|
|
|
As at |
As at |
|
31.03.18 |
31.12.17 |
Assets |
£m |
£m |
Loans and advances to subsidiaries |
23,381 |
23,970 |
Financial assets at fair value through the income statement |
4,564 |
4,782 |
Derivative financial instruments |
93 |
161 |
Investment in subsidiaries |
40,854 |
39,354 |
Other assets |
288 |
202 |
Total assets |
69,180 |
68,469 |
|
|
|
Liabilities |
|
|
Deposits at amortised cost |
495 |
500 |
Debt securities in issue |
23,120 |
22,110 |
Subordinated liabilities |
6,360 |
6,501 |
Other liabilities |
191 |
153 |
Total liabilities |
30,166 |
29,264 |
|
|
|
Equity |
|
|
Called up share capital and share premium |
22,061 |
22,045 |
Other equity instruments |
8,943 |
8,943 |
Other reserves |
394 |
480 |
Retained earnings |
7,616 |
7,737 |
Total equity |
39,014 |
39,205 |
|
|
|
Total liabilities and equity |
69,180 |
68,469 |
Investment in subsidiaries
The investment in subsidiaries of £40,854m (December 2017: £39,354m) predominately represents investments made into BBPLC, including £8,986m (December 2017: £8,986m) of AT1 securities.
Loans and advances to subsidiaries, subordinated liabilities and debt securities in issue
For the three months ended 31 March 2018, Barclays PLC issued £1,500m and €1,055m of Fixed Rate Senior Notes included within the debt securities in issue balance of £23,120m (December 2017: £22,110m). Barclays PLC did not issue any subordinated liabilities in the period.
Other reserves
As a result of the adoption of IFRS 9 on 1 January 2018, the available for sale reserve of £86m has been transferred to retained earnings.
Management of internal investments, loans and advances
Barclays PLC retains the discretion to manage the nature of its internal investments in subsidiaries according to their regulatory and business needs. Barclays PLC may invest capital and funding in BBPLC and other Group subsidiaries such as the Group Service Company, the US Intermediate Holding Company (IHC) and the UK ring-fenced bank. In October 2017, the Bank of England published a consultation on "Internal MREL" and following that consultation a final statement of policy is expected to be published in H118. Accordingly, during the course of 2018 Barclays expects to restructure certain investments in subsidiaries, including to subordinate internal MREL beneath operating liabilities, to the extent required to achieve compliance with internal MREL requirements which are expected to be in effect from 1 January 2019.
Barclays Non-Core Quarterly Results
The Barclays Non-Core segment was closed on 1 July 2017 with the residual assets and liabilities reintegrated into, and associated financial performance subsequently reported in, Barclays UK, Barclays International and Head Office. Financial results up until 30 June 2017 are reflected in the Barclays Non-Core segment within the Group's results.
Barclays Non-Core |
|
|
|
|
|
|
|
|
|
|
|
Q118 |
|
Q417 |
Q317 |
Q217 |
Q117 |
|
Q416 |
Q316 |
Q216 |
Income statement information |
£m |
|
£m |
£m |
£m |
£m |
|
£m |
£m |
£m |
Net interest income |
- |
|
- |
- |
(123) |
11 |
|
(54) |
78 |
40 |
Net trading income |
- |
|
- |
- |
(411) |
(77) |
|
(462) |
(288) |
(463) |
Net fee, commission and other income |
- |
|
- |
- |
78 |
(8) |
|
97 |
51 |
79 |
Total income |
- |
|
- |
- |
(456) |
(74) |
|
(419) |
(159) |
(344) |
Credit impairment charges and other provisions |
- |
|
- |
- |
(27) |
(3) |
|
(47) |
(20) |
(26) |
Net operating expenses |
- |
|
- |
- |
(483) |
(77) |
|
(466) |
(179) |
(370) |
Operating expenses excluding UK bank levy and litigation and conduct |
- |
|
- |
- |
(108) |
(148) |
|
(341) |
(311) |
(368) |
UK bank levy |
- |
|
- |
- |
- |
- |
|
(76) |
- |
- |
Litigation and conduct |
- |
|
- |
- |
(19) |
(9) |
|
(51) |
(102) |
(27) |
Operating expenses |
- |
|
- |
- |
(127) |
(157) |
|
(468) |
(413) |
(395) |
Other net income/(expenses) |
- |
|
- |
- |
204 |
(7) |
|
146 |
498 |
(324) |
Loss before tax |
- |
|
- |
- |
(406) |
(241) |
|
(788) |
(94) |
(1,089) |
Tax credit |
- |
|
- |
- |
207 |
75 |
|
322 |
194 |
229 |
(Loss)/profit after tax |
- |
|
- |
- |
(199) |
(166) |
|
(466) |
100 |
(860) |
Non-controlling interests |
- |
|
- |
- |
(8) |
(9) |
|
(14) |
(13) |
(12) |
Other equity instrument holders |
- |
|
- |
- |
(19) |
(18) |
|
(18) |
(15) |
(15) |
Attributable (loss)/profit |
- |
|
- |
- |
(226) |
(193) |
|
(498) |
72 |
(887) |
|
|
|
|
|
|
|
|
|
|
|
Balance sheet information |
£bn |
|
£bn |
£bn |
£bn |
£bn |
|
£bn |
£bn |
£bn |
Loans and advances to banks and customers at amortised cost |
- |
|
- |
- |
48.3 |
49.5 |
|
51.1 |
58.7 |
68.5 |
Derivative financial instrument assets |
- |
|
- |
- |
150.3 |
164.2 |
|
188.7 |
253.2 |
262.8 |
Derivative financial instrument liabilities |
- |
|
- |
- |
143.0 |
155.3 |
|
178.6 |
243.0 |
253.4 |
Reverse repurchase agreements and other similar secured lending |
- |
|
- |
- |
- |
- |
|
0.1 |
0.1 |
0.1 |
Financial assets designated at fair value |
- |
|
- |
- |
12.1 |
13.4 |
|
14.5 |
15.5 |
15.4 |
Total assets |
- |
|
- |
- |
233.0 |
249.1 |
|
279.7 |
359.8 |
379.1 |
Customer deposits |
- |
|
- |
- |
11.8 |
12.9 |
|
12.5 |
16.0 |
17.4 |
Risk weighted assets |
- |
|
- |
- |
22.8 |
27.4 |
|
32.1 |
43.9 |
46.7 |
Discontinued Operation Quarterly Results
Following the reduction of the Group's interest in BAGL in 2017, Barclays' remaining holding of 14.9%, as at Q118, is reported as a financial asset at fair value through other comprehensive income in the Head Office segment, with Barclays' share of BAGL's dividend recognised in the Head Office income statement.
For regulatory reporting purposes, BAGL is treated on a proportional consolidated basis. Subject to regulatory approval, Barclays expects to fully deconsolidate BAGL from a regulatory perspective by the end of 2018.
Africa Banking |
|
|
|
|
|
|
|
|
|
|
|
Q118 |
|
Q417 |
Q317 |
Q2171 |
Q117 |
|
Q416 |
Q316 |
Q216 |
Income statement information |
£m |
|
£m |
£m |
£m |
£m |
|
£m |
£m |
£m |
Net interest income |
- |
|
- |
- |
407 |
617 |
|
626 |
561 |
502 |
Net fee, commission and other income |
- |
|
- |
- |
297 |
465 |
|
441 |
421 |
377 |
Total income |
- |
|
- |
- |
704 |
1,082 |
|
1,067 |
982 |
879 |
Credit impairment charges and other provisions |
- |
|
- |
- |
(71) |
(106) |
|
(105) |
(96) |
(133) |
Net operating income |
- |
|
- |
- |
633 |
976 |
|
962 |
886 |
746 |
Operating expenses excluding UK bank levy and impairment of Barclays' holding in BAGL |
- |
|
- |
- |
(477) |
(653) |
|
(727) |
(598) |
(543) |
UK bank levy |
- |
|
- |
- |
- |
- |
|
(65) |
- |
- |
Other net income excluding loss on sale of BAGL |
- |
|
- |
- |
3 |
2 |
|
2 |
2 |
1 |
Profit before tax excluding impairment of Barclays' holding in BAGL and loss on sale of BAGL |
- |
|
- |
- |
159 |
325 |
|
172 |
290 |
204 |
Impairment of Barclays' holding in BAGL |
- |
|
- |
- |
(206) |
(884) |
|
- |
- |
- |
Loss on sale of BAGL |
- |
|
- |
- |
(1,435) |
- |
|
- |
- |
- |
(Loss)/profit before tax |
- |
|
- |
- |
(1,482) |
(559) |
|
172 |
290 |
204 |
(Loss)/profit after tax |
- |
|
- |
- |
(1,537) |
(658) |
|
71 |
209 |
145 |
Attributable (loss)/profit |
- |
|
- |
- |
(1,534) |
(801) |
|
(52) |
85 |
70 |
|
|
|
|
|
|
|
|
|
|
|
Balance sheet information |
£bn |
|
£bn |
£bn |
£bn |
£bn |
|
£bn |
£bn |
£bn |
Total assets |
- |
|
- |
- |
- |
66.0 |
|
65.1 |
61.1 |
56.0 |
Risk weighted assets2 |
- |
|
- |
- |
9.8 |
41.3 |
|
42.3 |
39.9 |
36.1 |
1 |
The Q217 Africa Banking income statement represents two months of results as a discontinued operation to 31 May 2017. |
2 |
RWAs at 31 March 2018 of £6.4bn (December 2017: £6.4bn) are reported in Head Office. |
Appendix: Non-IFRS Performance Measures
Barclays' management believes that the non-IFRS performance measures included in this document provide valuable information to the readers of the financial statements as they enable the reader to identify a more consistent basis for comparing the businesses' performance between financial periods, and provide more detail concerning the elements of performance which the managers of these businesses are most directly able to influence or are relevant for an assessment of Barclays PLC and its subsidiaries (the Group). They also reflect an important aspect of the way in which operating targets are defined and performance is monitored by Barclays' management.
Any non-IFRS performance measures in this document are not a substitute for IFRS measures and readers should consider the IFRS measures as well.
Non-IFRS performance measures glossary
Measure |
Definition |
Loan: deposit ratio |
Loans and advances at amortised cost divided by deposits at amortised cost. |
Period end allocated tangible equity |
Allocated tangible equity is calculated as 13.0% (2017: 12.0%) of risk weighted assets for each business, adjusted for capital deductions, excluding goodwill and intangible assets, reflecting the assumptions the Group uses for capital planning purposes. Head Office allocated tangible equity represents the difference between the Group's tangible shareholders' equity and the amounts allocated to businesses. |
Average tangible shareholders' equity |
Calculated as the average of the previous month's period end tangible equity and the current month's period end tangible equity. The average tangible shareholders' equity for the period is the average of the monthly averages within that period. |
Average allocated tangible equity |
Calculated as the average of the previous month's period end allocated tangible equity and the current month's period end allocated tangible equity. The average allocated tangible equity for the period is the average of the monthly averages within that period. |
Return on average tangible shareholders' equity |
Annualised statutory profit after tax attributable to ordinary shareholders, including an adjustment for the tax credit in reserves in respect of other equity instruments, as a proportion of average shareholders' equity excluding non-controlling interests and other equity instruments adjusted for the deduction of intangible assets and goodwill. The components of the calculation have been included on page 30. |
Return on average allocated tangible equity |
Annualised statutory profit after tax attributable to ordinary shareholders, including an adjustment for the tax credit in reserves in respect of other equity instruments, as a proportion of average allocated tangible equity. The components of the calculation have been included on page 30. |
Cost: income ratio |
Operating expenses divided by total income. |
Loan loss rate |
Quoted in basis points and represents total annualised impairment charges divided by gross loans and advances held at amortised cost at the balance sheet date. The components of the calculation have been included on page 14. |
Net interest margin |
Annualised net interest income divided by the sum of average customer assets. The components of the calculation have been included on page 13. |
Tangible net asset value per share |
Calculated by dividing shareholders' equity, excluding non-controlling interests and other equity instruments, less goodwill and intangible assets, by the number of issued ordinary shares. The components of the calculation have been included on page 34. |
Performance measures excluding litigation and conduct |
Calculated by excluding litigation and conduct charges from performance measures. The components of the calculations have been included on pages 31-33. |
Returns
Return on average tangible equity is calculated as annualised profit for the period attributable to ordinary equity holders of the parent (adjusted for the tax credit recorded in reserves in respect of interest payments on other equity instruments) divided by average tangible equity for the period, excluding non-controlling and other equity interests for businesses. Allocated tangible equity has been calculated as 13.0% (2017: 12.0%) of RWAs for each business, adjusted for capital deductions, excluding goodwill and intangible assets, reflecting the assumptions the Group uses for capital planning purposes. Head Office average allocated tangible equity represents the difference between the Group's average tangible shareholders' equity and the amounts allocated to businesses.
|
Attributable (loss)/profit |
Tax credit in respect of interest payments on other equity instruments |
(Loss)/profit attributable to ordinary equity holders of the parent |
|
Average tangible equity |
|
Return on average tangible equity |
Three months ended 31.03.18 |
£m |
£m |
£m |
|
£bn |
|
% |
Barclays UK |
(38) |
12 |
(26) |
|
9.8 |
|
(1.1) |
Corporate and Investment Bank |
805 |
29 |
834 |
|
25.6 |
|
13.0 |
Consumer, Cards and Payments |
168 |
5 |
173 |
|
4.5 |
|
15.6 |
Barclays International |
973 |
34 |
1,007 |
|
30.1 |
|
13.4 |
Head Office |
(1,699) |
- |
(1,699) |
|
4.3 |
|
n/m |
Barclays Group |
(764) |
46 |
(718) |
|
44.2 |
|
(6.5) |
|
|
|
|
|
|
|
|
Three months ended 31.03.17 |
|
|
|
|
|
|
|
Barclays UK |
470 |
9 |
479 |
|
8.9 |
|
21.6 |
Corporate and Investment Bank |
460 |
23 |
483 |
|
23.5 |
|
8.2 |
Consumer, Cards and Payments |
377 |
4 |
381 |
|
4.2 |
|
36.4 |
Barclays International |
837 |
27 |
864 |
|
27.7 |
|
12.5 |
Head Office1 |
(123) |
(3) |
(126) |
|
7.6 |
|
n/m |
Barclays Non-Core |
(193) |
5 |
(188) |
|
5.2 |
|
n/m |
Africa Banking discontinued operation1 |
(801) |
- |
(801) |
|
n/m |
|
n/m |
Barclays Group |
190 |
38 |
228 |
|
49.4 |
|
1.8 |
1 |
Average allocated tangible equity for Africa Banking is included within Head Office. |
Performance measures excluding litigation and conduct |
Barclays Group |
|
|
|
|
|
|
|
|
|
|
|
Q118 |
|
Q417 |
Q317 |
Q217 |
Q117 |
|
Q416 |
Q316 |
Q216 |
Profit before tax |
£m |
|
£m |
£m |
£m |
£m |
|
£m |
£m |
£m |
(Loss)/profit before tax |
(236) |
|
93 |
1,107 |
659 |
1,682 |
|
330 |
837 |
1,270 |
Impact of litigation and conduct |
1,961 |
|
383 |
81 |
715 |
28 |
|
97 |
741 |
447 |
Profit before tax excluding litigation and conduct |
1,725 |
|
476 |
1,188 |
1,374 |
1,710 |
|
427 |
1,578 |
1,717 |
|
|
|
|
|
|
|
|
|
|
|
Profit attributable to ordinary equity holders of the parent |
|
|
|
|
|
|
|
|
|
|
Attributable (loss)/profit |
(764) |
|
(1,294) |
583 |
(1,401) |
190 |
|
99 |
414 |
677 |
Impact of litigation and conduct1 |
1,930 |
|
351 |
77 |
703 |
19 |
|
52 |
726 |
447 |
Attributable profit/(loss) excluding litigation and conduct |
1,166 |
|
(943) |
660 |
(698) |
209 |
|
151 |
1,140 |
1,124 |
Tax credit in respect of interest payments on other equity instruments |
46 |
|
49 |
43 |
44 |
38 |
|
39 |
31 |
29 |
Profit/(loss) attributable to ordinary equity holders of the parent excluding litigation and conduct |
1,212 |
|
(894) |
703 |
(654) |
247 |
|
190 |
1,171 |
1,153 |
|
|
|
|
|
|
|
|
|
|
|
Return on average tangible shareholders' equity |
|
|
|
|
|
|
|
|
|
|
Average tangible shareholders' equity (£bn) |
44.2 |
|
48.1 |
48.9 |
49.3 |
49.4 |
|
48.9 |
49.4 |
48.3 |
|
|
|
|
|
|
|
|
|
|
|
Return on average tangible shareholders' equity excluding litigation and conduct |
11.0% |
|
(7.4%) |
5.7% |
(5.3%) |
2.0% |
|
1.6% |
9.5% |
9.5% |
|
|
|
|
|
|
|
|
|
|
|
Basic earnings per ordinary share |
|
|
|
|
|
|
|
|
|
|
Basic weighted average number of shares (m) |
17,037 |
|
16,996 |
16,994 |
16,989 |
16,924 |
|
16,860 |
16,866 |
16,859 |
|
|
|
|
|
|
|
|
|
|
|
Basic earnings/(loss) per ordinary share excluding litigation and conduct |
7.1p |
|
(5.3p) |
4.1p |
(3.8p) |
1.5p |
|
1.1p |
6.9p |
6.8p |
|
|
|
|
|
|
|
|
|
|
|
Cost: income ratio |
|
|
|
|
|
|
|
|
|
|
Operating expenses |
(5,325) |
|
(4,369) |
(3,355) |
(4,113) |
(3,619) |
|
(4,319) |
(4,322) |
(3,872) |
Impact of litigation and conduct |
1,961 |
|
383 |
81 |
715 |
28 |
|
97 |
741 |
447 |
Operating expenses excluding litigation and conduct |
(3,364) |
|
(3,986) |
(3,274) |
(3,398) |
(3,591) |
|
(4,222) |
(3,581) |
(3,425) |
|
|
|
|
|
|
|
|
|
|
|
Total income |
5,358 |
|
5,022 |
5,173 |
5,058 |
5,823 |
|
4,992 |
5,446 |
5,972 |
|
|
|
|
|
|
|
|
|
|
|
Cost: income ratio excluding litigation and conduct |
63% |
|
79% |
63% |
67% |
62% |
|
85% |
66% |
57% |
1 |
Represents the post-tax impact. |
Barclays UK |
|
|
|
|
|
|
|
|
|
|
|
Q118 |
|
Q417 |
Q317 |
Q217 |
Q117 |
|
Q416 |
Q316 |
Q216 |
Profit before tax |
£m |
|
£m |
£m |
£m |
£m |
|
£m |
£m |
£m |
Profit/(loss) before tax |
170 |
|
452 |
661 |
(74) |
708 |
|
583 |
75 |
376 |
Impact of litigation and conduct |
411 |
|
53 |
11 |
699 |
(4) |
|
28 |
614 |
399 |
Profit before tax excluding litigation and conduct |
581 |
|
505 |
672 |
625 |
704 |
|
611 |
689 |
775 |
|
|
|
|
|
|
|
|
|
|
|
Profit attributable to ordinary equity holders of the parent |
|
|
|
|
|
|
|
|
|
|
Attributable (loss)/profit |
(38) |
|
245 |
423 |
(285) |
470 |
|
383 |
(163) |
141 |
Impact of litigation and conduct1 |
411 |
|
37 |
8 |
691 |
(3) |
|
(3) |
627 |
410 |
Attributable profit excluding litigation and conduct |
373 |
|
282 |
431 |
406 |
467 |
|
380 |
464 |
551 |
Tax credit in respect of interest payments on other equity instruments |
12 |
|
13 |
9 |
9 |
9 |
|
7 |
7 |
8 |
Profit attributable to ordinary equity holders of the parent excluding litigation and conduct |
385 |
|
295 |
440 |
415 |
476 |
|
387 |
471 |
559 |
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity |
|
|
|
|
|
|
|
|
|
|
Average allocated tangible equity (£bn) |
9.8 |
|
9.6 |
9.4 |
8.7 |
8.9 |
|
8.6 |
8.7 |
9.0 |
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity excluding litigation and conduct |
15.7% |
|
12.3% |
18.7% |
19.1% |
21.5% |
|
18.0% |
21.6% |
24.9% |
|
|
|
|
|
|
|
|
|
|
|
Cost: income ratio |
|
|
|
|
|
|
|
|
|
|
Operating expenses |
(1,416) |
|
(1,229) |
(991) |
(1,673) |
(955) |
|
(1,065) |
(1,518) |
(1,346) |
Impact of litigation and conduct |
411 |
|
53 |
11 |
699 |
(4) |
|
28 |
614 |
399 |
Operating expenses excluding litigation and conduct |
(1,005) |
|
(1,176) |
(980) |
(974) |
(959) |
|
(1,037) |
(904) |
(947) |
|
|
|
|
|
|
|
|
|
|
|
Total income |
1,788 |
|
1,870 |
1,852 |
1,820 |
1,841 |
|
1,828 |
1,943 |
1,943 |
|
|
|
|
|
|
|
|
|
|
|
Cost: income ratio excluding litigation and conduct |
56% |
|
63% |
53% |
54% |
52% |
|
57% |
47% |
49% |
1 |
Represents the post-tax impact. |
Barclays International |
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Profit before tax |
£m |
|
£m |
£m |
£m |
£m |
£m |
£m |
£m |
|
Profit before tax |
1,413 |
|
6 |
652 |
1,261 |
1,356 |
|
373 |
1,085 |
1,726 |
Impact of litigation and conduct |
15 |
|
255 |
5 |
(4) |
13 |
|
17 |
17 |
10 |
Profit before tax excluding litigation and conduct |
||||||||||
|
||||||||||
Profit attributable to ordinary equity holders of the parent |
||||||||||
Attributable profit/(loss) |
973 |
|
(1,168) |
359 |
819 |
837 |
|
43 |
623 |
1,171 |
Impact of litigation and conduct1 |
12 |
|
250 |
4 |
(3) |
9 |
|
14 |
17 |
10 |
Attributable profit/(loss) excluding litigation and conduct |
||||||||||
Tax credit in respect of interest payments on other equity instruments |
34 |
|
34 |
32 |
27 |
27 |
|
23 |
20 |
19 |
Profit/(loss) attributable to ordinary equity holders of the parent excluding litigation and conduct |
||||||||||
|
||||||||||
Return on average allocated tangible equity |
|
|
|
|
|
|
|
|
|
|
Average allocated tangible equity (£bn) |
30.1 |
|
28.5 |
28.9 |
27.4 |
27.7 |
|
26.6 |
25.7 |
24.8 |
|
||||||||||
Return on average allocated tangible equity excluding litigation and conduct |
||||||||||
|
|
|
|
|
|
|
|
|
|
|
Cost: income ratio |
||||||||||
Operating expenses |
(2,315) |
|
(2,948) |
(2,187) |
(2,272) |
(2,448) |
|
(2,798) |
(2,354) |
(2,084) |
Impact of litigation and conduct |
15 |
|
255 |
5 |
(4) |
13 |
|
17 |
17 |
10 |
Operating expenses excluding litigation and conduct |
||||||||||
|
||||||||||
Total income |
3,808 |
|
3,319 |
3,315 |
3,610 |
4,138 |
|
3,592 |
3,851 |
4,039 |
|
||||||||||
Cost: income ratio excluding litigation and conduct |
Head Office |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Profit before tax |
|
|
|
|
|
|
|
|
|
|
(Loss)/profit before tax |
(1,819) |
|
(365) |
(206) |
(122) |
(141) |
|
162 |
(229) |
257 |
Impact of litigation and conduct |
1,535 |
|
75 |
65 |
1 |
10 |
|
1 |
8 |
11 |
(Loss)/profit before tax excluding litigation and conduct |
(284) |
|
(290) |
(141) |
(121) |
(131) |
|
163 |
(221) |
268 |
|
|
|
|
|
|
|
|
|
|
|
Profit attributable to ordinary equity holders of the parent |
|
|
|
|
|
|
|
|
|
|
Attributable (loss)/profit |
(1,699) |
|
(371) |
(199) |
(175) |
(123) |
|
223 |
(203) |
182 |
Impact of litigation and conduct1 |
1,507 |
|
64 |
65 |
1 |
7 |
|
1 |
8 |
7 |
Attributable (loss)/profit excluding litigation and conduct |
(192) |
|
(307) |
(134) |
(174) |
(116) |
|
224 |
(195) |
189 |
1 |
Represents the post-tax impact. |
Tangible net asset value |
As at |
As at |
As at |
|
31.03.18 |
31.12.17 |
31.03.17 |
|
£m |
£m |
£m |
Total equity excluding non-controlling interests |
59,519 |
63,905 |
65,536 |
Other equity instruments |
(8,941) |
(8,941) |
(7,690) |
Goodwill and intangibles1 |
(7,806) |
(7,849) |
(8,328) |
Tangible shareholders' equity attributable to ordinary shareholders of the parent |
42,772 |
47,115 |
49,518 |
|
|
|
|
|
m |
m |
m |
Shares in issue |
17,069 |
17,060 |
16,980 |
|
|
|
|
|
p |
p |
p |
Tangible net asset value per share |
251 |
276 |
292 |
1 |
Comparative figure as at March 2017 included goodwill and intangibles in relation to Africa Banking. |
Shareholder Information
Results timetable1 |
Date |
2018 Interim Results Announcement |
2 August 2018 |
|
|
|
|
|
% Change3 |
|
Exchange rates2 |
31.03.18 |
31.12.17 |
31.03.17 |
|
31.12.17 |
31.03.17 |
Period end - USD/GBP |
1.40 |
1.35 |
1.25 |
|
4% |
12% |
3 month average - USD/GBP |
1.39 |
1.33 |
1.24 |
|
5% |
12% |
Period end - EUR/GBP |
1.14 |
1.13 |
1.17 |
|
1% |
(3%) |
3 month average - EUR/GBP |
1.13 |
1.13 |
1.16 |
|
- |
(3%) |
|
|
|
|
|
|
|
Share price data |
|
|
|
|
|
|
Barclays PLC (p) |
206.50 |
203.10 |
225.10 |
|
|
|
Barclays PLC number of shares (m) |
17,069 |
17,060 |
16,980 |
|
|
|
|
|
|
|
|
|
|
For further information please contact |
|
|
|
|
|
|
|
|
|
|
|
|
|
Investor relations |
Media relations |
|
|
|||
Kathryn McLeland +44 (0) 20 7116 4943 |
Thomas Hoskin +44 (0) 20 7116 4755 |
|
|
|||
|
|
|
|
|
|
|
More information on Barclays can be found on our website: home.barclays. |
|
|
||||
|
|
|
|
|
|
|
Registered office |
|
|
|
|
|
|
1 Churchill Place, London, E14 5HP, United Kingdom. Tel: +44 (0) 20 7116 1000. Company number: 48839. |
||||||
|
|
|
|
|
|
|
Registrar |
|
|
|
|
|
|
Equiniti, Aspect House, Spencer Road, Lancing, West Sussex, BN99 6DA, United Kingdom. |
||||||
Tel: 0371 384 20554 from the UK or +44 (0) 121 415 7004 from overseas. |
1 |
Note that this date is provisional and subject to change. |
2 |
The average rates shown above are derived from daily spot rates during the year. |
3 |
The change is the impact to GBP reported information. |
4 |
Lines open 8.30am to 5.30pm (UK time), Monday to Friday, excluding UK public holidays in England and Wales. |
Notes
The terms Barclays or Group refer to Barclays PLC together with its subsidiaries. Unless otherwise stated, the income statement analysis compares the three months ended 31 March 2018 to the corresponding three months of 2017 and balance sheet analysis as at 31 March 2018 with comparatives relating to 31 December 2017 and 31 March 2017. The abbreviations '£m' and '£bn' represent millions and thousands of millions of Pounds Sterling respectively; the abbreviations '$m' and '$bn' represent millions and thousands of millions of US Dollars respectively; and the abbreviations '€m' and '€bn' represent millions and thousands of millions of Euros respectively.
There are a number of key judgement areas, for example impairment calculations, which are based on models and which are subject to ongoing adjustment and modifications. Reported numbers reflect best estimates and judgements at the given point in time.
Relevant terms that are used in this document but are not defined under applicable regulatory guidance or International Financial Reporting Standards (IFRS) are explained in the results glossary that can be accessed at home.barclays/results.
The information in this announcement, which was approved by the Board of Directors on 25 April 2018, does not comprise statutory accounts within the meaning of Section 434 of the Companies Act 2006. Statutory accounts for the year ended 31 December 2017, which included certain information required for the Joint Annual Report on Form 20-F of Barclays PLC and Barclays Bank PLC to the US Securities and Exchange Commission (SEC) and which contained an unqualified audit report under Section 495 of the Companies Act 2006 (which did not make any statements under Section 498 of the Companies Act 2006) have been delivered to the Registrar of Companies in accordance with Section 441 of the Companies Act 2006.
These results will be furnished as a Form 6-K to the SEC as soon as practicable following their publication. Once furnished with the SEC, copies of the Form 6-K will also be available from the Barclays Investor Relations website at home.barclays/results and from the SEC's website at www.sec.gov.
Barclays is a frequent issuer in the debt capital markets and regularly meets with investors via formal road-shows and other ad hoc meetings. Consistent with its usual practice, Barclays expects that from time to time over the coming quarter it will meet with investors globally to discuss these results and other matters relating to the Group.
Non-IFRS performance measures
Barclays' management believes that the non-IFRS performance measures included in this document provide valuable information to the readers of the financial statements as they enable the reader to identify a more consistent basis for comparing the businesses' performance between financial periods, and provide more detail concerning the elements of performance which the managers of these businesses are most directly able to influence or are relevant for an assessment of the Group. They also reflect an important aspect of the way in which operating targets are defined and performance is monitored by Barclays' management. However, any non-IFRS performance measures in this document are not a substitute for IFRS measures and readers should consider the IFRS measures as well. Refer to pages 29-34 for further information and calculations of non-IFRS performance measures included throughout this document, and the most directly comparable IFRS measures.
Forward-looking statements
This document contains certain forward-looking statements within the meaning of Section 21E of the US Securities Exchange Act of 1934, as amended, and Section 27A of the US Securities Act of 1933, as amended, with respect to the Group. Barclays cautions readers that no forward-looking statement is a guarantee of future performance and that actual results or other financial condition or performance measures could differ materially from those contained in the forward-looking statements. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements sometimes use words such as 'may', 'will', 'seek', 'continue', 'aim', 'anticipate', 'target', 'projected', 'expect', 'estimate', 'intend', 'plan', 'goal', 'believe', 'achieve' or other words of similar meaning. Examples of forward-looking statements include, among others, statements or guidance regarding or relating to the Group's future financial position, income growth, assets, impairment charges, provisions, business strategy, structural reform, capital, leverage and other regulatory ratios, payment of dividends (including dividend payout ratios and expected payment strategies), projected levels of growth in the banking and financial markets, projected costs or savings, any commitments and targets and the impact of any regulatory deconsolidation resulting from the sell down of the Group's interest in Barclays Africa Group Limited, estimates of capital expenditures and plans and objectives for future operations, projected employee numbers, IFRS 9 impacts and other statements that are not historical fact. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances. These may be affected by changes in legislation, the development of standards and interpretations under International Financial Reporting Standards including the implementation of IFRS 9, evolving practices with regard to the interpretation and application of accounting and regulatory standards, the outcome of current and future legal proceedings and regulatory investigations, future levels of conduct provisions, the policies and actions of governmental and regulatory authorities, geopolitical risks and the impact of competition. In addition, factors including (but not limited to) the following may have an effect: capital, leverage and other regulatory rules (including with regard to the future structure of the Group) applicable to past, current and future periods; UK, US, Africa, Eurozone and global macroeconomic and business conditions; the effects of continued volatility in credit markets; market related risks such as changes in interest rates and foreign exchange rates; effects of changes in valuation of credit market exposures; changes in valuation of issued securities; volatility in capital markets; changes in credit ratings of any entities within the Group or any securities issued by such entities; the potential for one or more countries exiting the Eurozone; the implications of the exercise by the United Kingdom of Article 50 of the Treaty of Lisbon and the disruption that may result in the UK and globally from the withdrawal of the United Kingdom from the European Union and the success of future acquisitions, disposals and other strategic transactions. A number of these influences and factors are beyond the Group's control. As a result, the Group's actual future results, dividend payments, and capital and leverage ratios may differ materially from the plans, goals, expectations and guidance set forth in the Group's forward-looking statements. Additional risks and factors which may impact the Group's future financial condition and performance are identified in our filings with the SEC (including, without limitation, our annual report on form 20-F for the fiscal year ended 31 December 2017), which are available on the SEC's website at www.sec.gov.
Subject to our obligations under the applicable laws and regulations of the United Kingdom and the United States in relation to disclosure and ongoing information, we undertake no obligation to update publicly or revise any forward-looking statements, whether as a result of new information, future events or otherwise.